CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: phenolic donor
Accession: CHEBI:139520
browse the term
Definition: Any phenol that acts as an electron donor.
Synonyms: related_synonym: Formula=C6H5OR; SMILES=OC1=CC=C([*])C=C1; a phenolic donor; phenolic donors
xref: MetaCyc:Phenolic-Donors; PMID:16098794
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
[1-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA
CTD
PMID:27837168
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ar
androgen receptor
multiple interactions
EXP
1-naphthol inhibits the reaction [Metribolone binds to AR protein]
CTD
PMID:3695475
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases abundance
ISO
CYP1A1 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases abundance affects binding decreases activity
ISO
CYP1A2 protein results in increased abundance of 1-naphthol 1-naphthol binds to CYP1A2 protein 1-naphthol results in decreased activity of CYP1A2 protein
CTD
PMID:15916432 PMID:16243959 PMID:32278787
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases abundance multiple interactions
ISO
CYP1B1 protein results in increased abundance of 1-naphthol [1-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA
CTD
PMID:16243959 PMID:27837168
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
increases abundance multiple interactions
ISO
CYP2A13 protein results in increased abundance of 1-naphthol [CYP2A13 protein results in increased oxidation of naphthalene] which results in increased abundance of 1-naphthol
CTD
PMID:27137136
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases abundance
ISO
CYP2B6 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases abundance
ISO
CYP2C19 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases abundance
ISO
CYP2C8 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases abundance
ISO
CYP2D6 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases abundance
ISO
CYP2E1 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases abundance
ISO
CYP3A4 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases abundance
ISO
CYP3A5 protein results in increased abundance of 1-naphthol
CTD
PMID:16243959
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Esr2
estrogen receptor 2
affects binding multiple interactions
ISO
ESR2 protein binds to 1-naphthol 1-naphthol inhibits the reaction [ESR2 protein binds to Estradiol]
CTD
PMID:22989670
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Jag1
jagged canonical Notch ligand 1
decreases expression
ISO
1-naphthol results in decreased expression of JAG1 mRNA
CTD
PMID:22989670
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
EXP
1-naphthol results in increased activity of NR1I2 protein
CTD
PMID:27665777
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
EXP
1-naphthol results in increased activity of NR1I3 protein
CTD
PMID:27665777
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrip1
nuclear receptor interacting protein 1
increases expression
ISO
1-naphthol results in increased expression of NRIP1 mRNA
CTD
PMID:22989670
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
G
Ppara
peroxisome proliferator activated receptor alpha
increases activity
EXP
1-naphthol results in increased activity of PPARA protein
CTD
PMID:27665777
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Sult1a1
sulfotransferase family 1A member 1
increases sulfation
ISO
SULT1A1 protein results in increased sulfation of 1-naphthol
CTD
PMID:15684482
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
1-naphthol binds to and results in decreased activity of THRB protein
CTD
PMID:18584933
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity
ISO
1-naphthol analog results in increased activity of TRPA1 protein
CTD
PMID:29658714
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
1-naphthol analog results in increased activity of TRPV3 protein
CTD
PMID:29658714
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases metabolic processing multiple interactions increases glucuronidation affects metabolic processing
EXP ISO
UGT1A6 protein results in increased metabolism of 1-naphthol beta-Naphthoflavone promotes the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol]; Diclofenac inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol]; Indomethacin inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol] Methylcholanthrene promotes the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol]; Paraquat promotes the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol] UGT1A6 gene polymorphism affects the metabolism of 1-naphthol; UGT1A6 protein affects the metabolism of 1-naphthol
CTD
PMID:7646562 PMID:9429234 PMID:12153725 PMID:12756209 PMID:15336321 PMID:19023562 PMID:22265884 PMID:22846377 More...
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a7c
UDP glucuronosyltransferase 1 family, polypeptide A7C
increases glucuronidation
EXP
UGT1A7 protein results in increased glucuronidation of 1-naphthol; UGT1A8 protein results in increased glucuronidation of 1-naphthol
CTD
PMID:15502008 PMID:22846377
NCBI chr 9:88,739,577...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of 1-naphthol
CTD
PMID:15044611 PMID:18816295
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2a1
UDP glucuronosyltransferase family 2 member A1
increases glucuronidation
ISO
UGT2A1 protein results in increased glucuronidation of 1-naphthol
CTD
PMID:21164388
NCBI chr14:20,521,018...20,545,934
Ensembl chr14:20,517,951...20,545,531
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases glucuronidation
EXP
UGT2B1 protein results in increased glucuronidation of 1-naphthol
CTD
PMID:8302279
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b15
UDP glucuronosyltransferase family 2 member B15
increases metabolic processing
EXP
UGT2B15 protein results in increased metabolism of 1-naphthol
CTD
PMID:7574722
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
G
Abcc1
ATP binding cassette subfamily C member 1
affects sulfation
ISO
ABCC1 protein affects the sulfation of 2-naphthol
CTD
PMID:14742140
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
[2-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA
CTD
PMID:27837168
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ar
androgen receptor
multiple interactions
EXP
2-naphthol inhibits the reaction [Metribolone binds to AR protein]
CTD
PMID:3695475
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Ces1d
carboxylesterase 1D
affects metabolic processing
ISO
CES1 protein affects the metabolism of 2-naphthol
CTD
PMID:12837533
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases abundance
ISO
CYP1A1 protein results in increased abundance of 2-naphthol
CTD
PMID:16243959
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases abundance affects binding decreases activity
ISO
CYP1A2 protein results in increased abundance of 2-naphthol 2-naphthol binds to CYP1A2 protein 2-naphthol results in decreased activity of CYP1A2 protein
CTD
PMID:15916432 PMID:16243959 PMID:32278787
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
[2-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA
CTD
PMID:27837168
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases abundance
ISO
CYP2B6 protein results in increased abundance of 2-naphthol
CTD
PMID:16243959
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases abundance
ISO
CYP2E1 protein results in increased abundance of 2-naphthol
CTD
PMID:16243959
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases abundance
ISO
CYP3A4 protein results in increased abundance of 2-naphthol
CTD
PMID:16243959
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Sult4a1
sulfotransferase family 4A, member 1
increases metabolic processing
ISO
SULT4A1 protein results in increased metabolism of 2-naphthol
CTD
PMID:12039030
NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
2-naphthol binds to and results in decreased activity of THRB protein
CTD
PMID:18584933
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases glucuronidation
EXP
UGT2B1 protein results in increased glucuronidation of 2-naphthol
CTD
PMID:8302279
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b15
UDP glucuronosyltransferase family 2 member B15
increases metabolic processing
EXP
UGT2B15 protein results in increased metabolism of 2-naphthol
CTD
PMID:7574722
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
G
Comt
catechol-O-methyltransferase
increases methylation
ISO
COMT protein results in increased methylation of 3-methoxycatechol
CTD
PMID:11160877
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
3-methoxycatechol results in increased expression of NFE2L2 mRNA
CTD
PMID:26862668
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
aspidin BB results in increased expression of BAX protein
CTD
PMID:23628508
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
aspidin BB results in decreased expression of BCL2 protein
CTD
PMID:23628508
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity increases expression
ISO
aspidin BB results in increased activity of CASP3 protein aspidin BB results in increased expression of CASP3 protein modified form
CTD
PMID:23628508
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccna2
cyclin A2
increases expression
ISO
aspidin BB results in increased expression of CCNA2 protein
CTD
PMID:23628508
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccne1
cyclin E1
increases expression
ISO
aspidin BB results in increased expression of CCNE1 protein
CTD
PMID:23628508
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cdk2
cyclin dependent kinase 2
increases expression
ISO
aspidin BB results in increased expression of CDK2 protein
CTD
PMID:23628508
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cycs
cytochrome c, somatic
affects localization
ISO
aspidin BB affects the localization of CYCS protein
CTD
PMID:23628508
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
E2f1
E2F transcription factor 1
increases expression
ISO
aspidin BB results in increased expression of E2F1 protein
CTD
PMID:23628508
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression
ISO
aspidin BB results in increased expression of PARP1 protein modified form
CTD
PMID:23628508
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Rb1
RB transcriptional corepressor 1
increases expression
ISO
aspidin BB results in increased expression of RB1 protein
CTD
PMID:23628508
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Ache
acetylcholinesterase
multiple interactions decreases activity
ISO EXP
[Carbaryl co-treated with Dichlorvos] results in decreased activity of ACHE protein; Obidoxime Chloride promotes the reaction [Carbaryl results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [Carbaryl results in decreased activity of ACHE protein] [Carbaryl co-treated with Chlorpyrifos] results in decreased activity of ACHE protein
CTD
PMID:4859365 PMID:7713347 PMID:14644616 PMID:16256972 PMID:19934164 PMID:21251949 PMID:23418109 PMID:23962483 PMID:25707986 PMID:33844597 More...
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Agxt
alanine--glyoxylate aminotransferase
decreases activity
EXP
Carbaryl results in decreased activity of AGXT protein
CTD
PMID:2119399
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO EXP
AHR protein affects the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; Carbaryl binds to and results in increased activity of AHR protein; Carbaryl inhibits the reaction [beta-Naphthoflavone binds to and results in increased activity of AHR protein]
CTD
PMID:9169082 PMID:9853009 PMID:17553063
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Alb
albumin
increases hydrolysis multiple interactions
EXP ISO
ALB protein results in increased hydrolysis of Carbaryl bis(4-nitrophenyl)phosphate inhibits the reaction [ALB protein results in increased hydrolysis of Carbaryl]
CTD
PMID:27665777
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ar
androgen receptor
affects binding
EXP
Carbaryl binds to AR protein
CTD
PMID:14565775
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bche
butyrylcholinesterase
decreases activity multiple interactions
EXP
Carbaryl results in decreased activity of BCHE protein [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
CTD
PMID:20708061 PMID:22649187
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2l11
Bcl2-like 11
decreases expression
ISO
Carbaryl results in decreased expression of BCL2L11 mRNA
CTD
PMID:27829164
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bdnf
brain-derived neurotrophic factor
decreases secretion
ISO
Carbaryl results in decreased secretion of BDNF protein
CTD
PMID:35292247
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Casp3
caspase 3
increases expression
EXP
Carbaryl results in increased expression of CASP3
CTD
PMID:27296064
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression
ISO
Carbaryl results in decreased expression of CEBPA mRNA
CTD
PMID:27829164
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
EXP
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]
CTD
PMID:14644616
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
EXP
Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
CTD
PMID:14644616
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]
CTD
PMID:14644616
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
multiple interactions
EXP
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
CTD
PMID:14644616
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases activity increases expression multiple interactions
ISO EXP
Carbaryl results in increased activity of CYP1A1 protein Carbaryl results in increased expression of CYP1A1 mRNA; Carbaryl results in increased expression of CYP1A1 protein AHR protein affects the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; Methoxsalen inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]
CTD
PMID:9169082 PMID:9858662 PMID:11226373
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression decreases activity
ISO EXP
Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] Carbaryl results in increased expression of CYP1A2 protein Carbaryl results in decreased activity of CYP1A2 protein
CTD
PMID:9858662 PMID:16790556
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases activity increases expression
ISO
Carbaryl results in increased activity of CYP2B6 protein Carbaryl results in increased expression of CYP2B6 mRNA
CTD
PMID:22310298
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions decreases activity
ISO
Carbaryl inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] Carbaryl results in decreased activity of CYP2E1 protein
CTD
PMID:22634058
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Carbaryl results in increased expression of CYP3A4 mRNA
CTD
PMID:22310298
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Carbaryl results in increased expression of DDIT3 mRNA
CTD
PMID:11226373
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
Carbaryl results in increased expression of DNAJB4 mRNA
CTD
PMID:27829164
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
Carbaryl results in increased expression of DNAJB9 mRNA
CTD
PMID:27829164
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
increases expression
ISO
Carbaryl results in increased expression of DNAJC3 mRNA
CTD
PMID:27829164
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
G
E2f5
E2F transcription factor 5
decreases expression
ISO
Carbaryl results in decreased expression of E2F5 mRNA
CTD
PMID:27829164
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
G
Enc1
ectodermal-neural cortex 1
decreases expression
ISO
Carbaryl results in decreased expression of ENC1 mRNA
CTD
PMID:27829164
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Esr1
estrogen receptor 1
multiple interactions
ISO
Carbaryl binds to and results in decreased activity of ESR1 protein; Carbaryl inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
CTD
PMID:9126867 PMID:16626760
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions decreases expression
ISO
Carbaryl binds to and results in decreased activity of ESR2 protein Carbaryl results in decreased expression of ESR2 mRNA
CTD
PMID:16626760 PMID:27829164
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression decreases expression
ISO
Carbaryl results in increased expression of FOS mRNA Carbaryl results in decreased expression of FOS mRNA
CTD
PMID:11226373 PMID:27829164
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxo1
forkhead box O1
decreases expression
ISO
Carbaryl results in decreased expression of FOXO1 mRNA
CTD
PMID:27829164
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
ISO
Carbaryl inhibits the reaction [FSHB protein results in increased expression of STAR mRNA]; Carbaryl inhibits the reaction [FSHB protein results in increased secretion of Progesterone]
CTD
PMID:16413094
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
G6pd
glucose-6-phosphate dehydrogenase
increases activity multiple interactions
EXP
Carbaryl results in increased activity of G6PD protein [Malathion co-treated with Carbaryl] results in increased activity of G6PD protein; Plant Extracts inhibits the reaction [[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein]
CTD
PMID:27214522
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
decreases expression
ISO
Carbaryl results in decreased expression of GADD45B mRNA
CTD
PMID:27829164
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Carbaryl results in increased expression of GCLM mRNA
CTD
PMID:27829164
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gpx5
glutathione peroxidase 5
increases expression
ISO
Carbaryl results in increased expression of GPX5 mRNA
CTD
PMID:27829164
NCBI chr17:43,436,126...43,443,074
Ensembl chr17:43,416,340...43,443,074
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
increases expression
EXP
Carbaryl results in increased expression of GRIN2B protein
CTD
PMID:28975519
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Carbaryl results in increased expression of HERPUD1 mRNA
CTD
PMID:27829164
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hmox1
heme oxygenase 1
increases expression
ISO
Carbaryl results in increased expression of HMOX1 mRNA
CTD
PMID:27829164
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
Carbaryl results in increased expression of HSPA5 mRNA
CTD
PMID:11226373 PMID:27829164
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
decreases expression
ISO
Carbaryl results in decreased expression of HSPA6 mRNA
CTD
PMID:27829164
NCBI chr13:83,273,176...83,274,317
G
Ifnb1
interferon beta 1
multiple interactions
ISO
Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein]
CTD
PMID:15907790 PMID:18177342
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Il2
interleukin 2
decreases response to substance
ISO
Carbaryl analog results in decreased susceptibility to IL2 protein; Carbaryl results in decreased susceptibility to IL2 protein
CTD
PMID:8349949
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Kyat1
kynurenine aminotransferase 1
decreases activity
EXP
Carbaryl results in decreased activity of KYAT1 protein
CTD
PMID:2119399
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
G
Map2
microtubule-associated protein 2
multiple interactions
ISO
Carbaryl promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA]
CTD
PMID:32949729
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mitf
melanocyte inducing transcription factor
decreases expression
ISO
Carbaryl results in decreased expression of MITF mRNA
CTD
PMID:27829164
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mtnr1a
melatonin receptor 1A
affects binding multiple interactions
ISO
Carbaryl binds to MTNR1A protein Carbaryl inhibits the reaction [Melatonin binds to MTNR1A protein]
CTD
PMID:28027439
NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919
G
Mtnr1b
melatonin receptor 1B
affects binding multiple interactions
ISO
Carbaryl binds to MTNR1B protein Carbaryl inhibits the reaction [Melatonin binds to MTNR1B protein]; Guanosine Triphosphate inhibits the reaction [Carbaryl inhibits the reaction [Melatonin binds to MTNR1B protein]]
CTD
PMID:28027439
NCBI chr 8:12,638,219...12,652,737
Ensembl chr 8:12,638,219...12,652,737
G
Nefh
neurofilament heavy chain
increases phosphorylation
ISO
Carbaryl results in increased phosphorylation of NEFH protein
CTD
PMID:16256972
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein]
CTD
PMID:15907790 PMID:17015962
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]
CTD
PMID:15907790
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression increases activity
ISO EXP
Carbaryl results in increased expression of NR1I2 mRNA Carbaryl results in increased activity of NR1I2 protein
CTD
PMID:22310298 PMID:27665777
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
EXP
Carbaryl results in increased activity of NR1I3 protein
CTD
PMID:27665777
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Otx2
orthodenticle homeobox 2
multiple interactions
ISO
Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]
CTD
PMID:32949729
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
G
Pax6
paired box 6
multiple interactions
ISO
Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of PAX6 mRNA]
CTD
PMID:32949729
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pdxk
pyridoxal kinase
decreases activity
ISO
Carbaryl results in decreased activity of PDXK protein
CTD
PMID:2547861
NCBI chr20:10,210,276...10,232,314
Ensembl chr20:10,210,289...10,232,110
G
Pgr
progesterone receptor
multiple interactions
ISO
Carbaryl inhibits the reaction [Progesterone results in increased activity of PGR protein]
CTD
PMID:9126867
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases activity
EXP
Carbaryl results in decreased activity of PNPLA6 protein
CTD
PMID:7713347
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
Carbaryl promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA]
CTD
PMID:32949729
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Ppara
peroxisome proliferator activated receptor alpha
increases activity
EXP
Carbaryl results in increased activity of PPARA protein
CTD
PMID:27665777
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:15907790
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Star
steroidogenic acute regulatory protein
multiple interactions decreases expression
ISO
Carbaryl inhibits the reaction [FSHB protein results in increased expression of STAR mRNA] Carbaryl results in decreased expression of STAR mRNA
CTD
PMID:16413094
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Tdo2
tryptophan 2,3-dioxygenase
decreases activity
ISO EXP
Carbaryl results in decreased activity of TDO2 protein
CTD
PMID:2119399 PMID:2547861
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
G
Tgfb2
transforming growth factor, beta 2
increases expression
ISO
Carbaryl results in increased expression of TGFB2 mRNA
CTD
PMID:27829164
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Thrb
thyroid hormone receptor beta
multiple interactions affects binding
ISO
Carbaryl binds to and results in decreased activity of THRB protein Carbaryl binds to THRB protein
CTD
PMID:18584933 PMID:28973306
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Tpo
thyroid peroxidase
increases activity
ISO
Carbaryl results in increased activity of TPO protein
CTD
PMID:21809831
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Wnt6
Wnt family member 6
decreases expression
ISO
Carbaryl results in decreased expression of WNT6 mRNA
CTD
PMID:27829164
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523
G
Xbp1
X-box binding protein 1
increases expression
ISO
Carbaryl results in increased expression of XBP1 mRNA
CTD
PMID:27829164
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO
dieckol results in decreased expression of and results in decreased phosphorylation of AKT1 protein dieckol results in decreased phosphorylation of AKT1 protein
CTD
PMID:31291034 PMID:36683349
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA] dieckol results in increased expression of BAX protein
CTD
PMID:33051972 PMID:33347706 PMID:36683349
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA] dieckol results in decreased expression of BCL2 protein
CTD
PMID:33051972 PMID:33347706 PMID:36683349
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity multiple interactions
ISO
dieckol results in increased activity of CASP3 protein dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]
CTD
PMID:31291034 PMID:33347706
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
dieckol results in increased activity of CASP8 protein
CTD
PMID:31291034
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity increases expression multiple interactions
ISO
dieckol results in increased activity of CASP9 protein dieckol results in increased expression of CASP9 protein dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]
CTD
PMID:31291034 PMID:33347706 PMID:36683349
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions decreases activity
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein] dieckol results in decreased activity of CAT protein
CTD
PMID:33051972 PMID:33347706
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
decreases expression
ISO
dieckol results in decreased expression of CCND1 protein
CTD
PMID:33051972 PMID:36683349
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdh1
cadherin 1
increases expression
ISO
dieckol results in increased expression of CDH1 protein
CTD
PMID:31291034
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
decreases expression
ISO
dieckol results in decreased expression of CDH2 protein
CTD
PMID:31291034
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
dieckol results in decreased expression of CDK4 protein
CTD
PMID:36683349
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
dieckol results in decreased expression of CDK6 protein
CTD
PMID:36683349
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased phosphorylation of FOS protein]
CTD
PMID:33164846
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]
CTD
PMID:33347706
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Il18
interleukin 18
multiple interactions
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL18 mRNA]
CTD
PMID:33347706
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions decreases expression
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein] dieckol inhibits the reaction [Particulate Matter results in increased expression of IL1B protein] dieckol results in decreased expression of IL1B protein
CTD
PMID:33051972 PMID:33164846 PMID:33347706
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein] dieckol inhibits the reaction [Particulate Matter results in increased expression of IL6 protein]
CTD
PMID:33164846 PMID:33347706
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased phosphorylation of JUN protein]
CTD
PMID:33164846
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein]
CTD
PMID:33164846
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein]
CTD
PMID:33164846
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mmp1
matrix metallopeptidase 1
decreases expression multiple interactions
ISO
dieckol results in decreased expression of MMP1 mRNA; dieckol results in decreased expression of MMP1 protein dieckol inhibits the reaction [Particulate Matter results in increased expression of MMP1 protein]
CTD
PMID:19330880 PMID:33164846
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
decreases expression multiple interactions
ISO
dieckol results in decreased expression of MMP13 mRNA; dieckol results in decreased expression of MMP13 protein dieckol inhibits the reaction [Particulate Matter results in increased expression of MMP13 protein]
CTD
PMID:19330880 PMID:33164846
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased expression of MMP2 protein]
CTD
PMID:33164846
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
decreases expression
ISO
dieckol results in decreased expression of MMP3 mRNA; dieckol results in decreased expression of MMP3 protein
CTD
PMID:19330880
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp8
matrix metallopeptidase 8
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased expression of MMP8 protein]
CTD
PMID:33164846
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mmp9
matrix metallopeptidase 9
decreases expression multiple interactions
ISO
dieckol results in decreased expression of MMP9 protein dieckol inhibits the reaction [Particulate Matter results in increased expression of MMP9 protein]
CTD
PMID:31291034 PMID:33164846
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mtor
mechanistic target of rapamycin kinase
decreases phosphorylation
ISO
dieckol results in decreased phosphorylation of MTOR protein
CTD
PMID:31291034 PMID:36683349
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased expression of NFKB1 protein]
CTD
PMID:33164846
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
dieckol affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFKBIA protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of NFKBIA protein]
CTD
PMID:33347706
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
decreases expression
ISO
dieckol results in decreased expression of NOS2 mRNA; dieckol results in decreased expression of NOS2 protein
CTD
PMID:19330880
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
dieckol results in decreased expression of PCNA protein
CTD
PMID:33051972 PMID:36683349
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
dieckol results in decreased expression of PLAU protein
CTD
PMID:31291034
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression multiple interactions
ISO
dieckol results in decreased expression of PTGS2 mRNA; dieckol results in decreased expression of PTGS2 protein dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]
CTD
PMID:19330880 PMID:33347706
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
dieckol inhibits the reaction [Particulate Matter results in increased expression of RELA protein]
CTD
PMID:33164846
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rps6kb1
ribosomal protein S6 kinase B1
decreases expression
ISO
dieckol results in decreased expression of RPS6KB1 protein
CTD
PMID:31291034
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TGFB1 mRNA]
CTD
PMID:33347706
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein] dieckol inhibits the reaction [Particulate Matter results in increased expression of TNF protein] dieckol results in decreased expression of TNF protein
CTD
PMID:33051972 PMID:33164846 PMID:33347706
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRP53 mRNA]
CTD
PMID:33347706
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Twist1
twist family bHLH transcription factor 1
decreases expression
ISO
dieckol results in decreased expression of TWIST1 protein
CTD
PMID:31291034
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
G
Vim
vimentin
decreases expression
ISO
dieckol results in decreased expression of VIM protein
CTD
PMID:31291034
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
eckol results in decreased phosphorylation of and results in decreased activity of AKT1 protein
CTD
PMID:21514314
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Casp8
caspase 8
multiple interactions
ISO
[eckol co-treated with temozolomide] results in increased cleavage of CASP8 protein
CTD
PMID:21514314
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ctnnb1
catenin beta 1
decreases expression
ISO
eckol results in decreased expression of CTNNB1 protein
CTD
PMID:21514314
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cybb
cytochrome b-245 beta chain
decreases expression
ISO
eckol results in decreased expression of CYBB protein
CTD
PMID:21514314
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Foxo3
forkhead box O3
increases phosphorylation multiple interactions
ISO
eckol results in increased phosphorylation of FOXO3 protein FOXO3 mutant form inhibits the reaction [eckol results in increased expression of SOD2 protein]
CTD
PMID:24700636
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
eckol results in decreased phosphorylation of and results in decreased activity of MAPK1 protein
CTD
PMID:21514314
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
eckol results in decreased phosphorylation of and results in decreased activity of MAPK3 protein
CTD
PMID:21514314
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Msi1
musashi RNA-binding protein 1
decreases expression
ISO
eckol results in decreased expression of MSI1 protein
CTD
PMID:21514314
NCBI chr12:41,158,301...41,251,134
Ensembl chr12:41,158,599...41,191,076
G
Nes
nestin
decreases expression
ISO
eckol results in decreased expression of NES protein
CTD
PMID:21514314
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Prom1
prominin 1
decreases expression
ISO
eckol results in decreased expression of PROM1 protein
CTD
PMID:21514314
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
decreases activity
ISO
eckol results in decreased activity of RAF1 protein
CTD
PMID:21514314
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
eckol inhibits the reaction [Hydrogen Peroxide results in decreased expression of and results in decreased activity of SOD2 protein]; FOXO3 mutant form inhibits the reaction [eckol results in increased expression of SOD2 protein] eckol results in increased expression of SOD2 mRNA; eckol results in increased expression of SOD2 protein
CTD
PMID:24700636
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox2
SRY-box transcription factor 2
decreases expression
ISO
eckol results in decreased expression of SOX2 protein
CTD
PMID:21514314
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
orcinol results in decreased activity of CYP1A1 protein
CTD
PMID:24667653
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
ISO
Phloroglucinol analog results in decreased phosphorylation of AKT1 protein
CTD
PMID:23178381
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Phloroglucinol metabolite results in increased expression of BAX protein
CTD
PMID:22796323
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Phloroglucinol metabolite results in decreased expression of BCL2 protein
CTD
PMID:22796323
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases cleavage
ISO
Phloroglucinol analog results in increased cleavage of CASP3 protein; Phloroglucinol metabolite results in increased cleavage of CASP3 protein
CTD
PMID:22796323 PMID:23178381
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases cleavage
ISO
Phloroglucinol metabolite results in increased cleavage of CASP9 protein
CTD
PMID:22796323
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccn2
cellular communication network factor 2
multiple interactions
ISO
Phloroglucinol analog inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein]
CTD
PMID:26054450
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Phloroglucinol results in increased expression of GCLC protein
CTD
PMID:20188716
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Phloroglucinol analog results in increased expression of GDF15 protein
CTD
PMID:23178381
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gsk3b
glycogen synthase kinase 3 beta
decreases phosphorylation
ISO
Phloroglucinol analog results in decreased phosphorylation of GSK3B protein
CTD
PMID:23178381
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Phloroglucinol analog results in increased cleavage of PARP1 protein; Phloroglucinol metabolite results in increased cleavage of PARP1 protein
CTD
PMID:22796323 PMID:23178381
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Smad2
SMAD family member 2
multiple interactions
ISO
Phloroglucinol analog inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]
CTD
PMID:26054450
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smad3
SMAD family member 3
multiple interactions
ISO
Phloroglucinol analog inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
CTD
PMID:26054450
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
Phloroglucinol analog inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein]; Phloroglucinol analog inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; Phloroglucinol analog inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
CTD
PMID:26054450
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Aanat
aralkylamine N-acetyltransferase
multiple interactions
EXP
Propranolol inhibits the reaction [Parathion results in increased expression of AANAT protein]
CTD
PMID:10685507
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression multiple interactions
ISO
Propranolol results in increased expression of ABCB1 mRNA Propranolol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]
CTD
PMID:15276086 PMID:16671962
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Ada
adenosine deaminase
multiple interactions
EXP
Propranolol promotes the reaction [ADA protein results in decreased susceptibility to Norepinephrine]
CTD
PMID:7949234
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adm
adrenomedullin
decreases response to substance
EXP
Propranolol results in decreased susceptibility to ADM protein
CTD
PMID:9845272
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adrb1
adrenoceptor beta 1
multiple interactions affects response to substance affects binding increases activity increases expression
EXP ISO
Propranolol binds to and results in decreased activity of ADRB1 protein; Propranolol inhibits the reaction [CGP 12177 binds to ADRB1 protein]; Propranolol inhibits the reaction [Dihydroalprenolol binds to ADRB1 protein] ADRB1 protein polymorphism affects the susceptibility to Propranolol Propranolol binds to ADRB1 protein [Propranolol binds to and results in decreased activity of ADRB1 protein] which results in decreased abundance of Cyclic AMP; [Propranolol co-treated with ADRB1] results in increased abundance of Cyclic AMP; Propranolol binds to and results in decreased activity of ADRB1 protein; Propranolol inhibits the reaction [[CGP 12177 binds to ADRB1 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [CGP 12177 results in increased activity of ADRB1 protein]; Propranolol inhibits the reaction [cyanopindolol binds to ADRB1 protein]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein]; Propranolol inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRB1 protein] Propranolol results in increased activity of ADRB1 protein Propranolol results in increased expression of ADRB1 mRNA
CTD
PMID:2462161 PMID:6141285 PMID:9593075 PMID:10372227 PMID:10952688 PMID:11425575 PMID:11483288 PMID:12761341 PMID:14502278 PMID:14730417 PMID:15060759 PMID:15627480 PMID:17200720 PMID:18787115 PMID:20668454 More...
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
decreases expression multiple interactions affects binding increases expression
ISO EXP
Propranolol results in decreased expression of ADRB2 mRNA Propranolol binds to and results in decreased activity of ADRB2 protein; Propranolol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; Propranolol inhibits the reaction [Dihydroalprenolol binds to ADRB2 protein] Propranolol binds to ADRB2 protein Propranolol results in increased expression of ADRB2 mRNA [Propranolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP; [Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein; [Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; [Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; [Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein; [Propranolol co-treated with ADRB2 protein] results in increased expression of GRK2 protein; Propranolol binds to and results in decreased activity of ADRB2 protein; Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [[Epinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [[Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [Albuterol binds to and results in increased activity of ADRB2 protein]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB2 protein binds to ARRB2 protein]]; Propranolol inhibits the reaction [carvedilol results in increased phosphorylation of ADRB2 protein]; Propranolol inhibits the reaction [cyanopindolol binds to ADRB2 protein]; Propranolol inhibits the reaction [Epinephrine binds to and results in increased activity of ADRB2 protein]; Propranolol inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; Propranolol inhibits the reaction [Norepinephrine binds to ADRB2 protein]; Propranolol inhibits the reaction [Terbutaline binds to and results in increased activity of ADRB2 protein]
CTD
PMID:2169833 PMID:2462161 PMID:2897299 PMID:6141285 PMID:9593075 PMID:10372227 PMID:10455254 PMID:10952688 PMID:11425575 PMID:11483288 PMID:12920204 PMID:14730417 PMID:15603589 PMID:17925438 PMID:20668454 PMID:24929186 More...
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Adrb3
adrenoceptor beta 3
multiple interactions affects response to substance
ISO
Propranolol inhibits the reaction [cyanopindolol binds to ADRB3 protein] ADRB3 affects the susceptibility to Propranolol
CTD
PMID:11159692 PMID:14730417
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
G
Agt
angiotensinogen
multiple interactions decreases expression
ISO
Propranolol inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; Propranolol inhibits the reaction [REN protein results in increased cleavage of AGT protein] Propranolol inhibits the reaction [AGT protein modified form results in increased abundance of Superoxides]; Propranolol inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]] Propranolol results in decreased expression of AGT protein
CTD
PMID:14627 PMID:1653766 PMID:7104148 PMID:7843740 PMID:12606818
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
Propranolol results in decreased phosphorylation of AKT1 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased phosphorylation of AKT1 protein]
CTD
PMID:30130526 PMID:31838054
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions
ISO
1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]
CTD
PMID:18218859
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Amy2a3
amylase 2a3
multiple interactions
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased secretion of and results in increased activity of AMY1A protein]
CTD
PMID:21173550
NCBI chr 2:201,317,916...201,326,487
Ensembl chr 2:201,317,920...201,326,532
G
Angpt2
angiopoietin 2
decreases expression multiple interactions
ISO
Propranolol results in decreased expression of ANGPT2 mRNA; Propranolol results in decreased expression of ANGPT2 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of BCL2 protein]; ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein]; ANGPT2 protein inhibits the reaction [Propranolol results in decreased phosphorylation of AKT1 protein]; ANGPT2 protein inhibits the reaction [Propranolol results in increased expression of BAX protein]
CTD
PMID:31838054
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
G
Arf6
ADP-ribosylation factor 6
affects localization
ISO
Propranolol affects the localization of ARF6 protein
CTD
PMID:16280360
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
G
Arrb2
arrestin, beta 2
multiple interactions
ISO
Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB2 protein binds to ARRB2 protein]]
CTD
PMID:17925438
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
EXP
Propranolol inhibits the reaction [Terbutaline results in increased expression of ATP1A1 mRNA]
CTD
PMID:9700104
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression multiple interactions increases expression
EXP ISO
Propranolol results in decreased expression of BAX mRNA Propranolol inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein] Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased expression of BAX protein] ANGPT2 protein inhibits the reaction [Propranolol results in increased expression of BAX protein]
CTD
PMID:11218852 PMID:31838054 PMID:35738838 PMID:36707890
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression multiple interactions decreases expression
EXP ISO
Propranolol results in increased expression of BCL2 mRNA Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein] Propranolol results in decreased expression of BCL2 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of BCL2 protein]
CTD
PMID:11218852 PMID:31838054 PMID:36707890
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdkrb2
bradykinin receptor B2
multiple interactions
ISO
BDKRB2 affects the susceptibility to [Propranolol co-treated with Atropine]
CTD
PMID:10614985
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Calca
calcitonin-related polypeptide alpha
multiple interactions affects activity
EXP
Propranolol promotes the reaction [CALCA protein affects the susceptibility to Norepinephrine] Propranolol affects the activity of CALCA protein
CTD
PMID:7906887 PMID:8058111 PMID:10075105 PMID:18055875
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
increases cleavage multiple interactions increases activity decreases expression
ISO EXP
Propranolol results in increased cleavage of CASP3 protein Acetylcysteine inhibits the reaction [Propranolol results in increased cleavage of CASP3 protein]; Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased cleavage of CASP3 protein] Propranolol results in increased activity of CASP3 protein Palmitic Acid promotes the reaction [Propranolol results in increased activity of CASP3 protein] Propranolol results in decreased expression of CASP3 mRNA
CTD
PMID:11218852 PMID:19106745 PMID:22700542 PMID:35738838
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity
ISO
Propranolol results in increased activity of CASP7 protein
CTD
PMID:22700542
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO EXP
Propranolol results in increased cleavage of CASP9 protein Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased cleavage of CASP9 protein]
CTD
PMID:19106745 PMID:35738838
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
Propranolol inhibits the reaction [Epinephrine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL3 protein]] Propranolol inhibits the reaction [Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Propranolol promotes the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]
CTD
PMID:9863660 PMID:12538206
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Col2a1
collagen type II alpha 1 chain
multiple interactions
ISO
Propranolol inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein]
CTD
PMID:21177286
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
Propranolol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein]
CTD
PMID:15522277
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
multiple interactions
EXP
Propranolol affects the reaction [Norepinephrine affects the expression of and affects the secretion of CRH protein]; Propranolol inhibits the reaction [acephate results in increased expression of CRH mRNA]; Propranolol inhibits the reaction [acephate results in increased secretion of CRH protein]; Propranolol inhibits the reaction [methamidophos results in increased expression of CRH mRNA]; Propranolol inhibits the reaction [methamidophos results in increased secretion of CRH protein]
CTD
PMID:3497798 PMID:12039681
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
ISO EXP
Propranolol results in increased expression of CYP1A1 protein Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein]]; Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein]] Propranolol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
CTD
PMID:15618653 PMID:15627480 PMID:15710352
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects metabolic processing increases expression multiple interactions
ISO EXP
CYP1A2 protein affects the metabolism of Propranolol Propranolol results in increased expression of CYP1A2 protein Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]]; Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]]
CTD
PMID:15286053 PMID:15618653 PMID:15710352
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
Propranolol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]
CTD
PMID:22167199
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases oxidation affects metabolic processing
ISO
CYP2C19 protein results in increased oxidation of Propranolol CYP2C19 protein affects the metabolism of Propranolol
CTD
PMID:15286053 PMID:19853591
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d2
cytochrome P450, family 2, subfamily d, polypeptide 2
multiple interactions
EXP
Propranolol inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin]
CTD
PMID:19858067
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases metabolic processing increases oxidation affects metabolic processing
ISO
CYP2D6 protein results in increased metabolism of Propranolol CYP2D6 protein results in increased oxidation of Propranolol CYP2D6 protein affects the metabolism of Propranolol
CTD
PMID:12464242 PMID:15286053 PMID:19853591 PMID:21184751
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases oxidation
ISO
CYP3A4 protein results in increased oxidation of Propranolol
CTD
PMID:19853591
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Dll4
delta like canonical Notch ligand 4
decreases expression multiple interactions
ISO
Propranolol results in decreased expression of DLL4 protein DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP2 protein]; DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein]
CTD
PMID:30130526
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]
CTD
PMID:18787115
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
multiple interactions
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein]
CTD
PMID:15621046
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Elk1
ETS transcription factor ELK1
multiple interactions
EXP
[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of ELK1 protein; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of ELK1 protein]
CTD
PMID:11880281
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Fas
Fas cell surface death receptor
decreases expression
EXP
Propranolol results in decreased expression of FAS mRNA
CTD
PMID:11218852
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fgf1
fibroblast growth factor 1
increases expression
EXP
Propranolol results in increased expression of FGF1 mRNA
CTD
PMID:15264218
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fmo2
flavin containing dimethylaniline monoxygenase 2
increases oxidation
ISO
FMO2 protein results in increased oxidation of Propranolol
CTD
PMID:26062974
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
G
Fn1
fibronectin 1
multiple interactions
ISO
[Norepinephrine co-treated with Propranolol] results in increased expression of FN1 protein
CTD
PMID:11821714
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
Propranolol inhibits the reaction [3-(N-phenylamino)-1,2-propanediol 1,2-dioleoyl ester analog results in increased expression of FOS mRNA]; Propranolol inhibits the reaction [Ethanol results in increased expression of FOS protein]; Propranolol inhibits the reaction [Haloperidol results in increased expression of FOS protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of FOS] Propranolol results in increased expression of FOS protein
CTD
PMID:7905536 PMID:9748542 PMID:15501433 PMID:22236039
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gad1
glutamate decarboxylase 1
multiple interactions
EXP
Propranolol inhibits the reaction [Amphetamine inhibits the reaction [3-acetylpyridine results in increased expression of GAD1 mRNA]]; Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [3-acetylpyridine results in increased expression of GAD1 mRNA]]
CTD
PMID:8774452
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gja1
gap junction protein, alpha 1
affects localization
EXP
Propranolol affects the localization of GJA1 protein
CTD
PMID:17445419
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gk
glycerol kinase
decreases activity
EXP
Propranolol results in decreased activity of GK protein
CTD
PMID:12736183
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Gnas
GNAS complex locus
increases expression multiple interactions
EXP ISO
Propranolol results in increased expression of GNAS mRNA [Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein
CTD
PMID:10455254 PMID:20668454
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Grk2
G protein-coupled receptor kinase 2
multiple interactions increases expression decreases expression
ISO
[Propranolol co-treated with ADRB2 protein] results in increased expression of GRK2 protein Propranolol results in increased expression of GRK2 protein Propranolol results in decreased expression of GRK2 protein
CTD
PMID:9788834 PMID:10455254
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Gsk3b
glycogen synthase kinase 3 beta
decreases phosphorylation
EXP
Propranolol results in decreased phosphorylation of GSK3B protein
CTD
PMID:22982863
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
Propranolol inhibits the reaction [Isoproterenol results in increased expression of HMOX1 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of HMOX1 mRNA]
CTD
PMID:19483313 PMID:24929186
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpca
hippocalcin
affects localization
EXP
Propranolol affects the localization of HPCA protein
CTD
PMID:21078978
NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
Propranolol binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Il10
interleukin 10
increases expression
EXP
Propranolol results in increased expression of IL10 mRNA
CTD
PMID:16908771
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions decreases secretion
ISO EXP
Propranolol promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] Propranolol results in decreased secretion of IL1B protein
CTD
PMID:11854442 PMID:16386803
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
EXP
Propranolol inhibits the reaction [Norepinephrine results in increased expression of IL6 mRNA]; Propranolol inhibits the reaction [Ozone results in increased expression of IL6 mRNA]; Propranolol inhibits the reaction [Ozone results in increased expression of IL6 protein]
CTD
PMID:12619890 PMID:29247675
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins2
insulin 2
multiple interactions decreases expression
ISO
Propranolol inhibits the reaction [Epinephrine results in decreased expression of INS protein] Propranolol results in decreased expression of INS protein
CTD
PMID:3019152 PMID:6018752
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Kcne2
potassium voltage-gated channel subfamily E regulatory subunit 2
multiple interactions
ISO
Propranolol results in decreased activity of [KCNH2 protein binds to KCNE2 protein]
CTD
PMID:15679475
NCBI chr11:31,517,176...31,530,026
Ensembl chr11:31,295,614...31,530,043
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Propranolol results in decreased activity of [KCNH2 protein binds to KCNE2 protein]; Propranolol results in decreased activity of [KCNH2 protein binds to KCNH2 protein] Propranolol results in decreased activity of KCNH2 protein
CTD
PMID:15679475 PMID:16314852
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnj2
potassium inwardly-rectifying channel, subfamily J, member 2
affects response to substance
ISO
KCNJ2 gene affects the susceptibility to Propranolol
CTD
PMID:15028050
NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
increases expression
ISO
Propranolol results in increased expression of KCNJ3 mRNA
CTD
PMID:15603589
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
G
Kcnq1
potassium voltage-gated channel subfamily Q member 1
affects response to substance
ISO
KCNQ1 gene affects the susceptibility to Propranolol
CTD
PMID:15028050
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
G
Lep
leptin
multiple interactions increases expression
ISO EXP
Propranolol inhibits the reaction [Isoproterenol results in decreased secretion of LEP protein] Propranolol results in increased expression of LEP protein
CTD
PMID:11022189 PMID:24250662
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
increases expression
EXP
Propranolol results in increased expression of LEPR mRNA
CTD
PMID:24250662
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lpl
lipoprotein lipase
multiple interactions
EXP
Propranolol inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA]
CTD
PMID:9032464
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO EXP
[Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein; Propranolol inhibits the reaction [Nicotine results in decreased phosphorylation of MAPK1 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein] 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; [Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein; Cadmium Chloride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; cadmium sulfate inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; N,N'-bis(salicylideneamino)ethane-manganese(II) inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; oxophenylarsine inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Prazosin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Propranolol inhibits the reaction [Colforsin results in increased activity of MAPK1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of MAPK1 protein]
CTD
PMID:11093795 PMID:11880281 PMID:17925438 PMID:18448488 PMID:19903766 PMID:20106947 More...
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO EXP
[Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; Propranolol inhibits the reaction [Nicotine results in decreased phosphorylation of MAPK3 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein] 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; [Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein; Cadmium Chloride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; cadmium sulfate inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; N,N'-bis(salicylideneamino)ethane-manganese(II) inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; oxophenylarsine inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Prazosin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Propranolol inhibits the reaction [Colforsin results in increased activity of MAPK3 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of MAPK3 protein]
CTD
PMID:11093795 PMID:11880281 PMID:17925438 PMID:18448488 PMID:19903766 PMID:20106947 More...
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions
ISO
Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MCL1 protein]
CTD
PMID:19903766
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mir34a
microRNA 34a
multiple interactions
ISO
Propranolol inhibits the reaction [Arsenic Trioxide results in increased expression of MIR34A mRNA]
CTD
PMID:36707890
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mki67
marker of proliferation Ki-67
decreases expression multiple interactions
ISO
Propranolol results in decreased expression of MKI67 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein]
CTD
PMID:31838054
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp2
matrix metallopeptidase 2
decreases expression multiple interactions decreases secretion
ISO
Propranolol results in decreased expression of MMP2; Propranolol results in decreased expression of MMP2 mRNA; Propranolol results in decreased expression of MMP2 protein DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP2 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA] Propranolol results in decreased secretion of MMP2 protein
CTD
PMID:20424515 PMID:21042766 PMID:24929186 PMID:30130526
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases expression multiple interactions decreases secretion
ISO
Propranolol results in decreased expression of MMP9; Propranolol results in decreased expression of MMP9 mRNA; Propranolol results in decreased expression of MMP9 protein DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]; Propranolol inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] Propranolol results in decreased secretion of MMP9 protein
CTD
PMID:16574429 PMID:20424515 PMID:21042766 PMID:24929186 PMID:30130526
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Myh7
myosin heavy chain 7
multiple interactions increases expression
EXP
Propranolol promotes the reaction [Norepinephrine results in increased expression of MYH7 mRNA]; Propranolol promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA] Propranolol results in increased expression of MYH7 mRNA
CTD
PMID:17592507
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
G
Nefh
neurofilament heavy chain
affects expression
EXP
Propranolol affects the expression of NEFH mRNA
CTD
PMID:22954530
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Ngf
nerve growth factor
multiple interactions
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased expression of NGF mRNA]
CTD
PMID:2174743 PMID:2853697
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nos3
nitric oxide synthase 3
affects expression
EXP
Propranolol affects the expression of NOS3
CTD
PMID:10889169
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
decreases expression
ISO
Propranolol results in decreased expression of NOTCH1 protein
CTD
PMID:30130526
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nppa
natriuretic peptide A
multiple interactions affects activity increases expression
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Propranolol promotes the reaction [Norepinephrine results in increased expression of NPPA mRNA]; Propranolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] Propranolol affects the activity of NPPA protein modified form Propranolol results in increased expression of NPPA mRNA
CTD
PMID:1363893 PMID:10997724 PMID:17592507
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
affects activity
EXP
Propranolol affects the activity of NPPB protein modified form
CTD
PMID:1363893
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Propranolol results in increased activity of NR1I2 protein
CTD
PMID:28259787
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Odc1
ornithine decarboxylase 1
increases activity multiple interactions
ISO
Propranolol results in increased activity of ODC1 protein Propranolol inhibits the reaction [Clenbuterol results in increased activity of ODC1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of ODC1 protein]
CTD
PMID:2286747 PMID:6284819 PMID:10353628
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Orm1
orosomucoid 1
affects binding
EXP
propranolol affects binding to Orm1 protein in rat serum
RGD
PMID:3252025
RGD:2316648
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Penk
proenkephalin
multiple interactions
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased expression of PENK mRNA]
CTD
PMID:1363325
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Pln
phospholamban
multiple interactions
EXP
Propranolol inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased phosphorylation of PLN protein]
CTD
PMID:10997724
NCBI chr20:32,629,537...32,639,559
G
Pomc
proopiomelanocortin
increases secretion
EXP
Propranolol results in increased secretion of POMC protein
CTD
PMID:22236039
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions decreases expression
ISO
[Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA]; Propranolol inhibits the reaction [Clenbuterol results in increased expression of PPARGC1A mRNA] Propranolol results in decreased expression of PPARGC1A mRNA
CTD
PMID:16513826 PMID:17446185
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkca
protein kinase C, alpha
decreases expression
EXP
Propranolol results in decreased expression of PRKCA protein
CTD
PMID:20668454
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkcd
protein kinase C, delta
decreases expression
EXP
Propranolol results in decreased expression of PRKCD protein
CTD
PMID:20668454
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression
ISO
Propranolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein]; Propranolol inhibits the reaction [Nicotine results in increased activity of PTGS2 protein]; Propranolol promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]; Propranolol promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Propranolol results in decreased expression of PTGS2; Propranolol results in decreased expression of PTGS2 mRNA; Propranolol results in decreased expression of PTGS2 protein
CTD
PMID:11854442 PMID:12872987 PMID:15210717 PMID:18805435 PMID:20424515 PMID:21042766 More...
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
multiple interactions
EXP
Propranolol inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein]
CTD
PMID:17623046
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Ren
renin
multiple interactions decreases activity decreases expression
ISO EXP
Propranolol affects the reaction [Anesthetics, Combined results in increased activity of REN protein]; Propranolol affects the reaction [Nitroprusside promotes the reaction [Anesthetics, Combined results in increased activity of REN protein]]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of REN protein]; Propranolol inhibits the reaction [Nitroprusside results in increased activity of REN protein]; Propranolol inhibits the reaction [REN protein results in increased cleavage of AGT protein] Propranolol results in decreased activity of REN protein Propranolol inhibits the reaction [ioxitalamic acid results in increased expression of REN protein]; Propranolol inhibits the reaction [Prazosin results in increased transport of REN protein]; Propranolol inhibits the reaction [Yohimbine results in increased expression of REN protein] Propranolol results in decreased expression of REN protein
CTD
PMID:145319 PMID:200433 PMID:637424 PMID:653302 PMID:791319 PMID:1103606 PMID:1653766 PMID:3539430 PMID:6110712 PMID:6323192 PMID:6346849 PMID:6434220 PMID:7020487 PMID:7104148 PMID:7988622 PMID:19945959 More...
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Rps6kb1
ribosomal protein S6 kinase B1
increases phosphorylation multiple interactions
ISO
Propranolol results in increased phosphorylation of RPS6KB1 protein Sirolimus inhibits the reaction [Propranolol results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:16537399
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Scnn1a
sodium channel epithelial 1 subunit alpha
multiple interactions
EXP
Propranolol inhibits the reaction [Terbutaline results in increased expression of SCNN1A mRNA]
CTD
PMID:9700104
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
G
Serpinf1
serpin family F member 1
increases expression
ISO
propranolol increases expression of Serpinf1 protein in mononuclear phagocytes
RGD
PMID:31682714
RGD:27226692
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Sirt1
sirtuin 1
multiple interactions
ISO
Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of SIRT1 mRNA]; Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of SIRT1 protein]
CTD
PMID:36707890
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc22a1
solute carrier family 22 member 1
multiple interactions
ISO
Propranolol inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
CTD
PMID:21641380
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Propranolol inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Propranolol inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin]
CTD
PMID:19740083
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a3
solute carrier family 22 member 3
multiple interactions
ISO
Propranolol inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
CTD
PMID:21641380
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc22a4
solute carrier family 22 member 4
multiple interactions
ISO
Propranolol inhibits the reaction [SLC22A4 protein results in increased uptake of Tetraethylammonium]
CTD
PMID:21641380
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO
Propranolol inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:21641380
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc47a1
solute carrier family 47 member 1
multiple interactions
ISO
Propranolol inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
CTD
PMID:22419765
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
G
Slc47a2
solute carrier family 47 member 2
multiple interactions
ISO
Propranolol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
CTD
PMID:22419765
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
G
Slc8a1
solute carrier family 8 member A1
multiple interactions
ISO
Propranolol inhibits the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein]
CTD
PMID:15621046
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]
CTD
PMID:18448488 PMID:20106947
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Sts
steroid sulfatase
multiple interactions
ISO
Propranolol inhibits the reaction [Tretinoin results in increased activity of STS protein]
CTD
PMID:16178010
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Tek
TEK receptor tyrosine kinase
decreases expression
ISO
Propranolol results in decreased expression of TEK mRNA; Propranolol results in decreased expression of TEK protein
CTD
PMID:31838054
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Thy1
Thy-1 cell surface antigen
multiple interactions
ISO
Propranolol inhibits the reaction [Epinephrine results in decreased expression of THY1]; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of THY1]; Propranolol inhibits the reaction [Norepinephrine results in decreased expression of THY1]
CTD
PMID:7558147
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP
Propranolol inhibits the reaction [Dopamine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]]; Propranolol inhibits the reaction [Ozone results in increased expression of TNF mRNA]; Propranolol inhibits the reaction [Ozone results in increased expression of TNF protein]; Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein] Propranolol results in increased expression of TNF protein
CTD
PMID:11752888 PMID:15081246 PMID:29247675
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ugt2b
UDP glycosyltransferase 2 family, polypeptide B
increases glucuronidation
EXP
UGT2B protein results in increased glucuronidation of Propranolol
CTD
PMID:15801678
NCBI chr14:20,630,572...20,665,062
Ensembl chr14:20,630,250...20,651,776
G
Vegfa
vascular endothelial growth factor A
decreases expression multiple interactions
ISO
Propranolol results in decreased expression of VEGFA mRNA; Propranolol results in decreased expression of VEGFA protein Propranolol inhibits the reaction [Norepinephrine results in increased expression of VEGFA mRNA]
CTD
PMID:10788502 PMID:20424515 PMID:30130526
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Adrb2
adrenoceptor beta 2
decreases binding
EXP
propranolol hydrochloride decreases binding to the beta2-adrenergic receptor
RGD
PMID:12875885
RGD:1598755
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
A2m
alpha-2-macroglobulin
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of A2M mRNA]
CTD
PMID:20362636
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Adarb1
adenosine deaminase, RNA-specific, B1
decreases expression
ISO
Pyrogallol results in decreased expression of ADARB1 mRNA
CTD
PMID:20362636
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
G
Add1
adducin 1
increases expression
ISO
Pyrogallol results in increased expression of ADD1 mRNA
CTD
PMID:20362636
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
G
Ak4
adenylate kinase 4
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of AK4 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of AK4 mRNA]
CTD
PMID:20362636
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akr1a1
aldo-keto reductase family 1 member A1
increases expression
ISO
Pyrogallol results in increased expression of AKR1A1 mRNA
CTD
PMID:20362636
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of ALDH1A1 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of ALDH1A1 mRNA]
CTD
PMID:20362636
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Alpl
alkaline phosphatase, biomineralization associated
increases expression
ISO
Pyrogallol results in increased expression of ALPL mRNA
CTD
PMID:20362636
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Ampd2
adenosine monophosphate deaminase 2
increases expression
ISO
Pyrogallol results in increased expression of AMPD2 mRNA
CTD
PMID:20362636
NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271
G
Anapc1
anaphase promoting complex subunit 1
increases expression
ISO
Pyrogallol results in increased expression of ANAPC1 mRNA
CTD
PMID:20362636
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
G
Ankrd6
ankyrin repeat domain 6
increases expression
ISO
Pyrogallol results in increased expression of ANKRD6 mRNA
CTD
PMID:20362636
NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090
G
Ap1g1
adaptor related protein complex 1 subunit gamma 1
increases expression
ISO
Pyrogallol results in increased expression of AP1G1 mRNA
CTD
PMID:20362636
NCBI chr19:37,744,633...37,831,134
Ensembl chr19:37,744,633...37,829,167
G
Apoa1
apolipoprotein A1
increases expression
ISO
Pyrogallol results in increased expression of APOA1 mRNA
CTD
PMID:20362636
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
App
amyloid beta precursor protein
multiple interactions
ISO
[Copper binds to APP protein alternative form] which results in increased oxidation of Pyrogallol; Hydrogen Peroxide promotes the reaction [[Copper binds to APP protein alternative form] which results in increased oxidation of Pyrogallol]
CTD
PMID:15699049
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Arf1
ADP-ribosylation factor 1
increases expression
ISO
Pyrogallol results in increased expression of ARF1 mRNA
CTD
PMID:20362636
NCBI chr10:43,997,983...44,014,461
Ensembl chr10:43,997,986...44,014,434
G
Arhgdia
Rho GDP dissociation inhibitor alpha
increases expression
ISO
Pyrogallol results in increased expression of ARHGDIA mRNA
CTD
PMID:20362636
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
multiple interactions decreases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in decreased expression of ASNS mRNA]
CTD
PMID:20362636
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
increases expression
ISO
Pyrogallol results in increased expression of ATP1B1 mRNA
CTD
PMID:20362636
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Bag4
BAG cochaperone 4
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of BAG4 mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of BAG4 mRNA]
CTD
PMID:20362636
NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
increases expression
ISO
Pyrogallol results in increased expression of BMI1 mRNA
CTD
PMID:20362636
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
G
Bmpr1a
bone morphogenetic protein receptor type 1A
increases expression
ISO
Pyrogallol results in increased expression of BMPR1A mRNA
CTD
PMID:20362636
NCBI chr16:9,736,390...9,829,825
Ensembl chr16:9,736,630...9,780,616
G
Btg4
BTG anti-proliferation factor 4
increases expression
ISO
Pyrogallol results in increased expression of BTG4 mRNA
CTD
PMID:20362636
NCBI chr 8:51,410,774...51,425,802
Ensembl chr 8:51,422,061...51,425,796
G
C1s
complement C1s
increases expression
ISO
Pyrogallol results in increased expression of C1S mRNA
CTD
PMID:20362636
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
Calml4
calmodulin-like 4
increases expression
ISO
Pyrogallol results in increased expression of CALML4 mRNA
CTD
PMID:20362636
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Car8
carbonic anhydrase 8
increases expression
ISO
Pyrogallol results in increased expression of CAR8 mRNA
CTD
PMID:20362636
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
G
Casp3
caspase 3
multiple interactions increases activity
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Pyrogallol results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Pyrogallol results in increased activity of CASP3 protein]; SB 203580 inhibits the reaction [Pyrogallol results in increased activity of CASP3 protein]
CTD
PMID:19000662 PMID:20191265
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
Pyrogallol results in increased activity of CASP8 protein
CTD
PMID:19000662
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression
ISO
Pyrogallol results in increased expression of CASP9 mRNA
CTD
PMID:20362636
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions increases activity decreases expression
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Pyrogallol results in decreased expression of CAT protein]; pyrazolanthrone promotes the reaction [Pyrogallol results in decreased expression of CAT protein]; SB 203580 promotes the reaction [Pyrogallol results in decreased expression of CAT protein] Pyrogallol results in increased activity of CAT protein acetovanillone inhibits the reaction [Pyrogallol results in increased activity of CAT protein]
CTD
PMID:20191265 PMID:35944648
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd2
cyclin D2
increases expression
ISO
Pyrogallol results in increased expression of CCND2 mRNA
CTD
PMID:20362636
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Cct3
chaperonin containing TCP1 subunit 3
increases expression
ISO
Pyrogallol results in increased expression of CCT3 mRNA
CTD
PMID:20362636
NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757
G
Cdh11
cadherin 11
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of CDH11 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of CDH11 mRNA]
CTD
PMID:20362636
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdk4
cyclin-dependent kinase 4
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of CDK4 mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of CDK4 mRNA]
CTD
PMID:20362636
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of CDKN1C mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of CDKN1C mRNA]
CTD
PMID:20362636
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cltc
clathrin heavy chain
increases expression
ISO
Pyrogallol results in increased expression of CLTC mRNA
CTD
PMID:20362636
NCBI chr10:71,517,661...71,574,591
Ensembl chr10:71,517,663...71,573,737
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Pyrogallol results in increased expression of COL1A1 mRNA
CTD
PMID:20362636
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Comt
catechol-O-methyltransferase
increases methylation
ISO
COMT protein results in increased methylation of Pyrogallol
CTD
PMID:11160877
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cox4i1
cytochrome c oxidase subunit 4i1
increases expression
ISO
Pyrogallol results in increased expression of COX4I1 mRNA
CTD
PMID:20362636
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
G
Cox6b1
cytochrome c oxidase subunit 6B1
decreases expression
ISO
Pyrogallol results in decreased expression of COX6B1 mRNA
CTD
PMID:20362636
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001
G
Cox7c
cytochrome c oxidase subunit 7C
increases expression
ISO
Pyrogallol results in increased expression of COX7C mRNA
CTD
PMID:20362636
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
G
Csnk2b
casein kinase 2 beta
increases expression
ISO
Pyrogallol results in increased expression of CSNK2B mRNA
CTD
PMID:20362636
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
G
Ctnnal1
catenin alpha-like 1
decreases expression
ISO
Pyrogallol results in decreased expression of CTNNAL1 mRNA
CTD
PMID:20362636
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
G
Cul3
cullin 3
increases expression
ISO
Pyrogallol results in increased expression of CUL3 mRNA
CTD
PMID:20362636
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
G
Cycs
cytochrome c, somatic
affects localization increases expression
ISO
Pyrogallol affects the localization of CYCS protein Pyrogallol results in increased expression of CYCS mRNA
CTD
PMID:19000662 PMID:20362636
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions increases activity
ISO
Pyrogallol results in increased expression of CYP1A2 mRNA resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP1A2 protein]; resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA]
CTD
PMID:18789925
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases activity multiple interactions increases expression
ISO
Pyrogallol results in increased activity of CYP2E1 protein resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP2E1 protein]; resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP2E1 mRNA]
CTD
PMID:18789925
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dcbld2
discoidin, CUB and LCCL domain containing 2
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of DCBLD2 mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of DCBLD2 mRNA]
CTD
PMID:20362636
NCBI chr11:42,125,525...42,179,927
Ensembl chr11:42,125,787...42,179,697
G
Ddx3x
DEAD-box helicase 3, X-linked
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of DDX3X mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of DDX3X mRNA]
CTD
PMID:20362636
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
G
Dlgap5
DLG associated protein 5
increases expression
ISO
Pyrogallol results in increased expression of DLGAP5 mRNA
CTD
PMID:20362636
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dnal4
dynein, axonemal, light chain 4
increases expression
ISO
Pyrogallol results in increased expression of DNAL4 mRNA
CTD
PMID:20362636
NCBI chr 7:111,312,424...111,325,283
Ensembl chr 7:111,312,427...111,325,283
G
Dnase2
deoxyribonuclease 2, lysosomal
increases expression
ISO
Pyrogallol results in increased expression of DNASE2A mRNA
CTD
PMID:20362636
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Eef1b2
eukaryotic translation elongation factor 1 beta 2
increases expression
ISO
Pyrogallol results in increased expression of EEF1B2 mRNA
CTD
PMID:20362636
NCBI chr 9:64,580,163...64,582,737
Ensembl chr 9:64,579,893...64,582,737
G
Eef2
eukaryotic translation elongation factor 2
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of EEF2 mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of EEF2 mRNA]
CTD
PMID:20362636
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Eif1a
eukaryotic translation initiation factor 1A
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of EIF1A mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of EIF1A mRNA]
CTD
PMID:20362636
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:39,325,202...39,338,696
G
Eif4e2
eukaryotic translation initiation factor 4E family member 2
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of EIF4E2 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of EIF4E2 mRNA]
CTD
PMID:20362636
NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482
G
Eif4enif1
eukaryotic translation initiation factor 4E nuclear import factor 1
decreases expression
ISO
Pyrogallol results in decreased expression of EIF4ENIF1 mRNA
CTD
PMID:20362636
NCBI chr14:78,056,115...78,099,846
Ensembl chr14:78,056,297...78,098,793
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
increases expression
ISO
Pyrogallol results in increased expression of EIF4G1 mRNA
CTD
PMID:20362636
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
G
Eno1
enolase 1
increases expression
ISO
Pyrogallol results in increased expression of ENO1 mRNA
CTD
PMID:20362636
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Epo
erythropoietin
decreases expression
EXP
Pyrogallol results in decreased expression of EPO protein
CTD
PMID:9927288
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ermap
erythroblast membrane associated protein (Scianna blood group)
increases expression
ISO
Pyrogallol results in increased expression of ERMAP mRNA
CTD
PMID:20362636
NCBI chr 5:132,788,847...132,803,030
Ensembl chr 5:132,789,991...132,802,847
G
Esd
esterase D
increases expression
ISO
Pyrogallol results in increased expression of ESD mRNA
CTD
PMID:20362636
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Fah
fumarylacetoacetate hydrolase
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of FAH mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of FAH mRNA]
CTD
PMID:20362636
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fkbp4
FKBP prolyl isomerase 4
increases expression
ISO
Pyrogallol results in increased expression of FKBP4 mRNA
CTD
PMID:20362636
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
increases expression
ISO
Pyrogallol results in increased expression of GART mRNA
CTD
PMID:20362636
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gata4
GATA binding protein 4
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of GATA4 mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of GATA4 mRNA]
CTD
PMID:20362636
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
Gnb1
G protein subunit beta 1
increases expression
ISO
Pyrogallol results in increased expression of GNB1 mRNA
CTD
PMID:20362636
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
G
Gpx1
glutathione peroxidase 1
decreases activity multiple interactions
EXP
Pyrogallol results in decreased activity of GPX1 protein acetovanillone inhibits the reaction [Pyrogallol results in increased activity of GPX1 protein]
CTD
PMID:35944648
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsr
glutathione-disulfide reductase
decreases activity multiple interactions
ISO
Pyrogallol results in decreased activity of GSR protein resveratrol inhibits the reaction [Pyrogallol results in decreased activity of GSR protein]
CTD
PMID:18789925
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hars1
histidyl-tRNA synthetase 1
decreases expression
ISO
Pyrogallol results in decreased expression of HARS1 mRNA
CTD
PMID:20362636
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
G
Hba-a1
hemoglobin alpha, adult chain 1
increases expression
ISO
Pyrogallol results in increased expression of HBA1 mRNA
CTD
PMID:20362636
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
G
Hdgfl2
HDGF like 2
increases expression
ISO
Pyrogallol results in increased expression of HDGFL2 mRNA
CTD
PMID:20362636
NCBI chr 9:909,581...929,195
Ensembl chr 9:909,614...929,186
G
Hint1
histidine triad nucleotide binding protein 1
increases expression
ISO
Pyrogallol results in increased expression of HINT1 mRNA
CTD
PMID:20362636
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
increases expression
ISO
Pyrogallol results in increased expression of HNRNPDL mRNA
CTD
PMID:20362636
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
ISO
Pyrogallol results in increased expression of HPRT1 mRNA
CTD
PMID:20362636
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
Pyrogallol results in increased expression of HSP90AA1 mRNA
CTD
PMID:20362636
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of HSPA8 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of HSPA8 mRNA]
CTD
PMID:20362636
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Il6
interleukin 6
multiple interactions increases expression
EXP
acetovanillone inhibits the reaction [Pyrogallol results in increased expression of IL6 protein]
CTD
PMID:35944648
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Iqgap1
IQ motif containing GTPase activating protein 1
increases expression
ISO
Pyrogallol results in increased expression of IQGAP1 mRNA
CTD
PMID:20362636
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
Pyrogallol results in increased expression of ISG20 mRNA
CTD
PMID:20362636
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itfg1
integrin alpha FG-GAP repeat containing 1
increases expression
ISO
Pyrogallol results in increased expression of ITFG1 mRNA
CTD
PMID:20362636
NCBI chr19:21,210,697...21,331,285
Ensembl chr19:21,210,733...21,331,279
G
Itm2b
integral membrane protein 2B
increases expression
ISO
Pyrogallol results in increased expression of ITM2B mRNA
CTD
PMID:20362636
NCBI chr15:48,545,998...48,568,904
Ensembl chr15:48,546,001...48,568,917
G
Kcmf1
potassium channel modulatory factor 1
increases expression
ISO
Pyrogallol results in increased expression of KCMF1 mRNA
CTD
PMID:20362636
NCBI chr 4:104,888,452...104,950,234
Ensembl chr 4:104,889,847...104,950,234
G
Kif5b
kinesin family member 5B
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of KIF5B mRNA]
CTD
PMID:20362636
NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
G
Kifap3
kinesin-associated protein 3
increases expression
ISO
Pyrogallol results in increased expression of KIFAP3 mRNA
CTD
PMID:20362636
NCBI chr13:76,127,702...76,264,654
Ensembl chr13:76,127,696...76,264,650
G
Klf4
KLF transcription factor 4
increases expression
ISO
Pyrogallol results in increased expression of KLF4 mRNA
CTD
PMID:20362636
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Krt18
keratin 18
increases expression
ISO
Pyrogallol results in increased expression of KRT18 mRNA
CTD
PMID:20362636
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Lamp2
lysosomal-associated membrane protein 2
increases expression
ISO
Pyrogallol results in increased expression of LAMP2 mRNA
CTD
PMID:20362636
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Lpo
lactoperoxidase
multiple interactions
EXP
acetovanillone inhibits the reaction [Pyrogallol results in increased activity of LPO protein]
CTD
PMID:35944648
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
G
Map4
microtubule-associated protein 4
increases expression
ISO
Pyrogallol results in increased expression of MAP4 mRNA
CTD
PMID:20362636
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
G
Mapk13
mitogen activated protein kinase 13
increases expression
ISO
Pyrogallol results in increased expression of MAPK13 mRNA
CTD
PMID:20362636
NCBI chr20:6,835,277...6,845,500
Ensembl chr20:6,835,320...6,844,222
G
Mbtps1
membrane-bound transcription factor peptidase, site 1
increases expression
ISO
Pyrogallol results in increased expression of MBTPS1 mRNA
CTD
PMID:20362636
NCBI chr19:47,561,598...47,612,769
Ensembl chr19:47,561,598...47,612,791
G
Mif
macrophage migration inhibitory factor
decreases expression
ISO
Pyrogallol results in decreased expression of MIF mRNA
CTD
PMID:20362636
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mmp23
matrix metallopeptidase 23
increases expression
ISO
Pyrogallol results in increased expression of MMP23 mRNA
CTD
PMID:20362636
NCBI chr 5:166,239,643...166,242,734
Ensembl chr 5:166,239,644...166,242,433
G
Mrps25
mitochondrial ribosomal protein S25
increases expression
ISO
Pyrogallol results in increased expression of MRPS25 mRNA
CTD
PMID:20362636
NCBI chr 4:124,668,320...124,680,086
Ensembl chr 4:124,668,094...124,680,057
G
Msrb1
methionine sulfoxide reductase B1
increases expression
ISO
Pyrogallol results in increased expression of MSRB1 mRNA
CTD
PMID:20362636
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
G
Nap1l1
nucleosome assembly protein 1-like 1
increases expression
ISO
Pyrogallol results in increased expression of NAP1L1 mRNA
CTD
PMID:20362636
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
G
Ndufb10
NADH:ubiquinone oxidoreductase subunit B10
increases expression
ISO
Pyrogallol results in increased expression of NDUFB10 mRNA
CTD
PMID:20362636
NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
ISO
Pyrogallol results in decreased expression of NFE2L2 mRNA
CTD
PMID:31967339
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nrk
Nik related kinase
decreases expression
ISO
Pyrogallol results in decreased expression of NRK mRNA
CTD
PMID:20362636
NCBI chr X:102,365,765...102,462,957
Ensembl chr X:102,365,765...102,459,657
G
Nubp1
NUBP iron-sulfur cluster assembly factor 1
increases expression
ISO
Pyrogallol results in increased expression of NUBP1 mRNA
CTD
PMID:20362636
NCBI chr10:5,259,328...5,270,848
G
Nup58
nucleoporin 58
increases expression
ISO
Pyrogallol results in increased expression of NUP58 mRNA
CTD
PMID:20362636
NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060
G
Pcna
proliferating cell nuclear antigen
increases expression
ISO
Pyrogallol results in increased expression of PCNA mRNA
CTD
PMID:20362636
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pdcd10
programmed cell death 10
increases expression
ISO
Pyrogallol results in increased expression of PDCD10 mRNA
CTD
PMID:20362636
NCBI chr 2:160,303,465...160,346,086
Ensembl chr 2:160,303,449...160,346,018
G
Pdia3
protein disulfide isomerase family A, member 3
increases expression
ISO
Pyrogallol results in increased expression of PDIA3 mRNA
CTD
PMID:20362636
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
Peli1
pellino E3 ubiquitin protein ligase 1
multiple interactions decreases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in decreased expression of PELI1 mRNA]
CTD
PMID:20362636
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
G
Pex14
peroxisomal biogenesis factor 14
decreases expression
ISO
Pyrogallol results in decreased expression of PEX14 mRNA
CTD
PMID:20362636
NCBI chr 5:159,399,776...159,536,260
Ensembl chr 5:159,399,776...159,536,272
G
Pfdn1
prefoldin subunit 1
increases expression
ISO
Pyrogallol results in increased expression of PFDN1 mRNA
CTD
PMID:20362636
NCBI chr18:28,014,145...28,067,148
Ensembl chr18:28,014,145...28,067,064
G
Phb1
prohibitin 1
increases expression
ISO
Pyrogallol results in increased expression of PHB1 mRNA
CTD
PMID:20362636
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Phgdh
phosphoglycerate dehydrogenase
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of PHGDH mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of PHGDH mRNA]
CTD
PMID:20362636
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
decreases expression
ISO
Pyrogallol results in decreased expression of PHKA2 mRNA
CTD
PMID:20362636
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
G
Pidd1
p53-induced death domain protein 1
increases expression
ISO
Pyrogallol results in increased expression of PIDD1 mRNA
CTD
PMID:20362636
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Pkig
cAMP-dependent protein kinase inhibitor gamma
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of PKIG mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of PKIG mRNA]
CTD
PMID:20362636
NCBI chr 3:152,330,477...152,398,085
Ensembl chr 3:152,366,041...152,398,082
G
Plp2
proteolipid protein 2
increases expression
ISO
Pyrogallol results in increased expression of PLP2 mRNA
CTD
PMID:20362636
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
G
Plxdc2
plexin domain containing 2
increases expression
ISO
Pyrogallol results in increased expression of PLXDC2 mRNA
CTD
PMID:20362636
NCBI chr17:79,169,238...79,594,279
Ensembl chr17:79,196,369...79,585,282
G
Polr1f
RNA polymerase I subunit F
increases expression
ISO
Pyrogallol results in increased expression of POLR1F mRNA
CTD
PMID:20362636
NCBI chr 6:50,053,289...50,070,514
Ensembl chr 6:50,053,289...50,070,514
G
Ppil4
peptidylprolyl isomerase like 4
increases expression
ISO
Pyrogallol results in increased expression of PPIL4 mRNA
CTD
PMID:20362636
NCBI chr 1:2,273,582...2,305,639
Ensembl chr 1:2,273,609...2,305,632
G
Prdx1
peroxiredoxin 1
increases expression
ISO
Pyrogallol results in increased expression of PRDX1 mRNA
CTD
PMID:20362636
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx3
peroxiredoxin 3
increases expression
ISO
Pyrogallol results in increased expression of PRDX3 mRNA
CTD
PMID:20362636
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
G
Prdx6
peroxiredoxin 6
increases expression
ISO
Pyrogallol results in increased expression of PRDX6 mRNA
CTD
PMID:20362636
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Psmc1
proteasome 26S subunit, ATPase 1
multiple interactions decreases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in decreased expression of PSMC1 mRNA]
CTD
PMID:20362636
NCBI chr 6:119,392,833...119,405,233
Ensembl chr 6:119,392,855...119,410,123
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression
EXP
acetovanillone inhibits the reaction [Pyrogallol results in increased expression of PTGS2 protein]
CTD
PMID:35944648
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptov1
PTOV1, extended AT-hook containing adaptor protein
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of PTOV1 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of PTOV1 mRNA]
CTD
PMID:20362636
NCBI chr 1:95,347,065...95,354,514
Ensembl chr 1:95,347,068...95,353,613
G
Ptp4a2
protein tyrosine phosphatase 4A2
increases expression
ISO
Pyrogallol results in increased expression of PTP4A2 mRNA
CTD
PMID:20362636
NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:142,165,700...142,191,899
G
Pygl
glycogen phosphorylase L
increases expression
ISO
Pyrogallol results in increased expression of PYGL mRNA
CTD
PMID:20362636
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
increases expression
ISO
Pyrogallol results in increased expression of RAF1 mRNA
CTD
PMID:20362636
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Rb1cc1
RB1-inducible coiled-coil 1
increases expression
ISO
Pyrogallol results in increased expression of RB1CC1 mRNA
CTD
PMID:20362636
NCBI chr 5:13,161,648...13,225,560
Ensembl chr 5:13,161,648...13,225,560
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
increases expression
ISO
Pyrogallol results in increased expression of RBBP4 mRNA
CTD
PMID:20362636
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rbbp9
RB binding protein 9, serine hydrolase
increases expression
ISO
Pyrogallol results in increased expression of RBBP9 mRNA
CTD
PMID:20362636
NCBI chr 3:131,925,095...131,939,042
Ensembl chr 3:131,925,341...131,932,156
G
Reps1
RALBP1 associated Eps domain containing 1
increases expression
ISO
Pyrogallol results in increased expression of REPS1 mRNA
CTD
PMID:20362636
NCBI chr 1:12,697,742...12,775,562
Ensembl chr 1:12,697,747...12,775,561
G
Rnf11
ring finger protein 11
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of RNF11 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of RNF11 mRNA]
CTD
PMID:20362636
NCBI chr 5:124,212,433...124,243,125
Ensembl chr 5:124,212,445...124,234,750
G
Rnf4
ring finger protein 4
increases expression
ISO
Pyrogallol results in increased expression of RNF4 mRNA
CTD
PMID:20362636
NCBI chr14:76,401,292...76,423,270
Ensembl chr14:76,401,299...76,422,566
G
Rogdi
rogdi atypical leucine zipper
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of ROGDI mRNA]
CTD
PMID:20362636
NCBI chr10:10,567,834...10,572,453
Ensembl chr10:10,567,834...10,572,452
G
Rpl10a
ribosomal protein L10A
increases expression
ISO
Pyrogallol results in increased expression of RPL10A mRNA
CTD
PMID:20362636
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357
G
Rpl12
ribosomal protein L12
increases expression
ISO
Pyrogallol results in increased expression of RPL12 mRNA
CTD
PMID:20362636
NCBI chr 3:16,264,269...16,266,645
Ensembl chr 3:16,264,251...16,266,642
G
Rpl23
ribosomal protein L23
increases expression
ISO
Pyrogallol results in increased expression of RPL23 mRNA
CTD
PMID:20362636
NCBI chr10:82,771,878...82,775,840
Ensembl chr10:82,771,538...82,775,870
G
Rpl26
ribosomal protein L26
increases expression decreases expression
ISO
Pyrogallol results in increased expression of RPL26 mRNA Pyrogallol results in decreased expression of RPL26 mRNA
CTD
PMID:20362636
NCBI chr10:53,610,836...53,613,966
Ensembl chr10:53,610,421...53,613,966
G
Rpl31
ribosomal protein L31
increases expression multiple interactions
ISO
Pyrogallol results in increased expression of RPL31 mRNA Silymarin inhibits the reaction [Pyrogallol results in increased expression of RPL31 mRNA]
CTD
PMID:20362636
NCBI chr 9:41,647,397...41,651,441
Ensembl chr 9:41,647,426...41,662,129
G
Rpl5
ribosomal protein L5
decreases expression increases expression
ISO
Pyrogallol results in decreased expression of RPL5 mRNA Pyrogallol results in increased expression of RPL5 mRNA
CTD
PMID:20362636
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rpl8
ribosomal protein L8
increases expression
ISO
Pyrogallol results in increased expression of RPL8 mRNA
CTD
PMID:20362636
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
G
Rps12
ribosomal protein S12
decreases expression
ISO
Pyrogallol results in decreased expression of RPS12 mRNA
CTD
PMID:20362636
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
G
Rps20
ribosomal protein S20
increases expression
ISO
Pyrogallol results in increased expression of RPS20 mRNA
CTD
PMID:20362636
NCBI chr 5:16,819,095...16,820,476
Ensembl chr 5:16,819,304...16,820,475 Ensembl chr 9:16,819,304...16,820,475 Ensembl chr 3:16,819,304...16,820,475
G
Rpsa
ribosomal protein SA
increases expression
ISO
Pyrogallol results in increased expression of RPSA mRNA
CTD
PMID:20362636
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
G
Rras2
RAS related 2
increases expression
ISO
Pyrogallol results in increased expression of RRAS2 mRNA
CTD
PMID:20362636
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rtn4
reticulon 4
increases expression
ISO
Pyrogallol results in increased expression of RTN4 mRNA
CTD
PMID:20362636
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Sars1
seryl-tRNA synthetase 1
increases expression
ISO
Pyrogallol results in increased expression of SARS1 mRNA
CTD
PMID:20362636
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Scamp2
secretory carrier membrane protein 2
increases expression
ISO
Pyrogallol results in increased expression of SCAMP2 mRNA
CTD
PMID:20362636
NCBI chr 8:57,965,612...57,992,248
Ensembl chr 8:57,965,631...57,992,646
G
Scp2
sterol carrier protein 2
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of SCP2 mRNA]
CTD
PMID:20362636
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
increases expression
ISO
Pyrogallol results in increased expression of SDHA mRNA
CTD
PMID:20362636
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
G
Selenow
selenoprotein W
increases expression
ISO
Pyrogallol results in increased expression of SELENOW mRNA
CTD
PMID:20362636
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Senp6
SUMO specific peptidase 6
increases expression
ISO
Pyrogallol results in increased expression of SENP6 mRNA
CTD
PMID:20362636
NCBI chr 8:80,988,675...81,071,606
Ensembl chr 8:80,989,052...81,067,170
G
Sfpq
splicing factor proline and glutamine rich
increases expression
ISO
Pyrogallol results in increased expression of SFPQ mRNA
CTD
PMID:20362636
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Slbp
stem-loop histone mRNA binding protein
increases expression
ISO
Pyrogallol results in increased expression of SLBP mRNA
CTD
PMID:20362636
NCBI chr14:77,071,441...77,081,911
Ensembl chr14:77,071,632...77,081,906
G
Slc12a2
solute carrier family 12 member 2
decreases expression
ISO
Pyrogallol results in decreased expression of SLC12A2 mRNA
CTD
PMID:20362636
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Snca
synuclein alpha
multiple interactions
ISO
Pyrogallol inhibits the reaction [SNCA protein binds to SNCA protein]
CTD
PMID:20150427
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Snta1
syntrophin, alpha 1
increases expression
ISO
Pyrogallol results in increased expression of SNTA1 mRNA
CTD
PMID:20362636
NCBI chr 3:142,876,285...142,906,737
Ensembl chr 3:142,876,296...142,906,709
G
Snx9
sorting nexin 9
increases expression
ISO
Pyrogallol results in increased expression of SNX9 mRNA
CTD
PMID:20362636
NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036
G
Socs6
suppressor of cytokine signaling 6
increases expression
ISO
Pyrogallol results in increased expression of SOCS6 mRNA
CTD
PMID:20362636
NCBI chr18:82,111,866...82,139,193
Ensembl chr18:82,111,827...82,139,219
G
Sod1
superoxide dismutase 1
decreases activity
EXP
Pyrogallol results in decreased activity of SOD1 protein
CTD
PMID:35944648
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Spr
sepiapterin reductase
increases expression
ISO
Pyrogallol results in increased expression of SPR mRNA
CTD
PMID:20362636
NCBI chr 4:117,671,948...117,676,292
Ensembl chr 4:117,671,949...117,675,678
G
Sptlc1
serine palmitoyltransferase, long chain base subunit 1
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of SPTLC1 mRNA]
CTD
PMID:20362636
NCBI chr17:11,877,249...11,916,295
Ensembl chr17:11,877,249...11,916,295
G
Ssbp3
single stranded DNA binding protein 3
increases expression
ISO
Pyrogallol results in increased expression of SSBP3 mRNA
CTD
PMID:20362636
NCBI chr 5:121,691,370...121,828,035
Ensembl chr 5:121,691,393...121,827,992
G
St8sia2
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
multiple interactions decreases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in decreased expression of ST8SIA2 mRNA]
CTD
PMID:20362636
NCBI chr 1:127,762,573...127,838,017
Ensembl chr 1:127,762,573...127,838,091
G
Stmn3
stathmin 3
increases expression
ISO
Pyrogallol results in increased expression of STMN3 mRNA
CTD
PMID:20362636
NCBI chr 3:168,416,810...168,424,946
Ensembl chr 3:168,416,810...168,425,056
G
Strn4
striatin 4
increases expression
ISO
Pyrogallol results in increased expression of STRN4 mRNA
CTD
PMID:20362636
NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858
G
Sv2a
synaptic vesicle glycoprotein 2a
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of SV2A mRNA]
CTD
PMID:20362636
NCBI chr 2:183,741,489...183,757,290
Ensembl chr 2:183,741,547...183,756,927
G
Syt4
synaptotagmin 4
increases expression
ISO
Pyrogallol results in increased expression of SYT4 mRNA
CTD
PMID:20362636
NCBI chr18:23,036,973...23,046,380
Ensembl chr18:23,038,378...23,046,332
G
Tdp2
tyrosyl-DNA phosphodiesterase 2
increases expression
ISO
Pyrogallol results in increased expression of TDP2 mRNA
CTD
PMID:20362636
NCBI chr17:40,228,943...40,240,337
Ensembl chr17:40,228,947...40,240,313
G
Tgoln2
trans-golgi network protein 2
increases expression
ISO
Pyrogallol results in increased expression of TGOLN1 mRNA
CTD
PMID:20362636
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Timm17b
translocase of inner mitochondrial membrane 17b
increases expression
ISO
Pyrogallol results in increased expression of TIMM17B mRNA
CTD
PMID:20362636
NCBI chr X:14,596,330...14,603,491
Ensembl chr X:14,594,577...14,603,416
G
Tirap
TIR domain containing adaptor protein
increases expression
ISO
Pyrogallol results in increased expression of TIRAP mRNA
CTD
PMID:20362636
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
G
Tnk2
tyrosine kinase, non-receptor, 2
increases expression
ISO
Pyrogallol results in increased expression of TNK2 mRNA
CTD
PMID:20362636
NCBI chr11:68,114,725...68,154,254
Ensembl chr11:68,114,726...68,154,009
G
Tnnt1
troponin T1, slow skeletal type
multiple interactions decreases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in decreased expression of TNNT1 mRNA]
CTD
PMID:20362636
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
pyrazolanthrone inhibits the reaction [Pyrogallol results in increased expression of TP53 protein]; SB 203580 inhibits the reaction [Pyrogallol results in increased expression of TP53 protein]
CTD
PMID:20191265
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ubap2
ubiquitin-associated protein 2
increases expression
ISO
Pyrogallol results in increased expression of UBAP2 mRNA
CTD
PMID:20362636
NCBI chr 5:56,348,243...56,437,403
Ensembl chr 5:56,348,246...56,437,049
G
Ubb
ubiquitin B
increases expression
ISO
Pyrogallol results in increased expression of UBB mRNA
CTD
PMID:20362636
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
G
Ubc
ubiquitin C
increases expression
ISO
Pyrogallol results in increased expression of UBC mRNA
CTD
PMID:20362636
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Ube4b
ubiquitination factor E4B
increases expression
ISO
Pyrogallol results in increased expression of UBE4B mRNA
CTD
PMID:20362636
NCBI chr 5:159,766,829...159,870,509
Ensembl chr 5:159,766,829...159,870,509
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
ISO
Pyrogallol results in increased expression of UCHL1 mRNA
CTD
PMID:20362636
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
Pyrogallol results in increased expression of UGDH mRNA
CTD
PMID:20362636
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Usp10
ubiquitin specific peptidase 10
increases expression
ISO
Pyrogallol results in increased expression of USP10 mRNA
CTD
PMID:20362636
NCBI chr19:47,972,858...48,014,900
Ensembl chr19:47,972,611...48,014,897
G
Vdac1
voltage-dependent anion channel 1
increases expression
ISO
Pyrogallol results in increased expression of VDAC1 mRNA
CTD
PMID:20362636
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vim
vimentin
multiple interactions increases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in increased expression of VIM mRNA]
CTD
PMID:20362636
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vps26c
VPS26 endosomal protein sorting factor C
multiple interactions decreases expression
ISO
Silymarin inhibits the reaction [Pyrogallol results in decreased expression of VPS26C mRNA]
CTD
PMID:20362636
NCBI chr11:33,813,467...33,841,883
Ensembl chr11:33,792,389...33,841,447
G
Vps72
vacuolar protein sorting 72 homolog
decreases expression multiple interactions
ISO
Pyrogallol results in decreased expression of VPS72 mRNA Silymarin inhibits the reaction [Pyrogallol results in decreased expression of VPS72 mRNA]
CTD
PMID:20362636
NCBI chr 2:182,678,594...182,690,185
Ensembl chr 2:182,678,609...182,690,182
G
Zfp91
zinc finger protein 91
increases expression
ISO
Pyrogallol results in increased expression of ZFP91 mRNA
CTD
PMID:20362636
NCBI chr 1:209,891,344...209,928,890
Ensembl chr 1:209,891,344...209,927,762
G
Acyp1
acylphosphatase 1
increases expression
ISO
resorcinol results in increased expression of ACYP1 mRNA
CTD
PMID:22623647
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
G
Ahr
aryl hydrocarbon receptor
affects activity
ISO
resorcinol affects the activity of AHR protein
CTD
PMID:18294747
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akap12
A-kinase anchoring protein 12
increases expression
ISO
resorcinol results in increased expression of AKAP12 mRNA
CTD
PMID:22623647
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
resorcinol results in increased expression of AKR1B10 mRNA
CTD
PMID:22623647 PMID:26198647 PMID:30806763
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
resorcinol results in increased expression of AKR1C1 mRNA
CTD
PMID:30806763
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
resorcinol inhibits the reaction [[[MPO protein co-treated with Chlorides co-treated with Threonine co-treated with Hydrogen Peroxide] results in increased chemical synthesis of Acrolein] which results in increased phosphorylation of AKT1 protein] resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein]
CTD
PMID:26262998
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Ankrd37
ankyrin repeat domain 37
increases expression
ISO
resorcinol results in increased expression of ANKRD37 mRNA
CTD
PMID:22623647
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Apbb2
amyloid beta precursor protein binding family B member 2
decreases expression
ISO
resorcinol results in decreased expression of APBB2 mRNA
CTD
PMID:22623647
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
G
Apc
APC regulator of WNT signaling pathway
multiple interactions
ISO
resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein]
CTD
PMID:26262998
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
ISO
resorcinol results in increased expression of AQP3 mRNA
CTD
PMID:22623647
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Ar
androgen receptor
affects activity
ISO
resorcinol affects the activity of AR protein
CTD
PMID:18294747
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arrdc3
arrestin domain containing 3
decreases expression
ISO
resorcinol results in decreased expression of ARRDC3 mRNA
CTD
PMID:22623647
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Atf3
activating transcription factor 3
increases expression
ISO
resorcinol results in increased expression of ATF3 mRNA
CTD
PMID:27965148
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf7ip
activating transcription factor 7 interacting protein
decreases expression
ISO
resorcinol results in decreased expression of ATF7IP mRNA
CTD
PMID:22623647
NCBI chr 4:169,385,872...169,471,652
Ensembl chr 4:169,385,872...169,471,650
G
Atxn7l3b
ataxin 7-like 3B
increases expression
ISO
resorcinol results in increased expression of ATXN7L3B mRNA
CTD
PMID:22623647
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression
ISO
resorcinol results in decreased expression of BAMBI mRNA
CTD
PMID:22623647
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bhlhe40
basic helix-loop-helix family, member e40
increases expression
ISO
resorcinol results in increased expression of BHLHE40 mRNA
CTD
PMID:22623647
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Blcap
BLCAP, apoptosis inducing factor
increases expression
ISO
resorcinol results in increased expression of BLCAP mRNA
CTD
PMID:22623647
NCBI chr 3:146,222,699...146,232,859
Ensembl chr 3:146,222,240...146,232,909
G
Brox
BRO1 domain and CAAX motif containing
decreases expression
ISO
resorcinol results in decreased expression of BROX mRNA
CTD
PMID:22623647
NCBI chr13:94,920,107...94,940,189
Ensembl chr13:94,920,112...94,940,227
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
resorcinol results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
C10h17orf100
similar to human chromosome 17 open reading frame 100
increases expression
ISO
resorcinol results in increased expression of C17ORF100 mRNA
CTD
PMID:22623647
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
G
C15h14orf119
similar to human chromosome 14 open reading frame 119
increases expression
ISO
resorcinol results in increased expression of C14ORF119 mRNA
CTD
PMID:22623647
NCBI chr15:28,146,368...28,151,422
Ensembl chr15:28,146,333...28,155,180
G
C2h4orf3
similar to human chromosome 4 open reading frame 3
increases expression
ISO
resorcinol results in increased expression of C4ORF3 mRNA
CTD
PMID:22623647
NCBI chr 2:211,055,925...211,057,685
Ensembl chr 2:211,055,911...211,057,681
G
C2h4orf46
similar to human chromosome 4 open reading frame 46
increases expression
ISO
resorcinol results in increased expression of C4ORF46 mRNA
CTD
PMID:22623647
NCBI chr 2:164,762,994...164,766,126
Ensembl chr 2:164,762,960...164,766,128
G
C2h5orf34
similar to human chromosome 5 open reading frame 34
decreases expression
ISO
resorcinol results in decreased expression of C5ORF34 mRNA
CTD
PMID:22623647
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
G
C5ar1
complement C5a receptor 1
decreases expression
ISO
resorcinol results in decreased expression of C5AR1 mRNA
CTD
PMID:22623647
NCBI chr 1:76,948,622...76,959,826
G
Carf
calcium responsive transcription factor
decreases expression
ISO
resorcinol results in decreased expression of CARF mRNA
CTD
PMID:22623647
NCBI chr 9:61,502,368...61,552,433
Ensembl chr 9:61,506,956...61,550,462
G
Ccr7
C-C motif chemokine receptor 7
increases expression
ISO
resorcinol results in increased expression of CCR7 mRNA
CTD
PMID:21697260
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Cct6b
chaperonin containing TCP1 subunit 6B
decreases expression
ISO
resorcinol results in decreased expression of CCT6B mRNA
CTD
PMID:22623647
NCBI chr10:67,652,461...67,701,385
Ensembl chr10:67,652,546...67,701,284
G
Cd83
CD83 molecule
increases expression
ISO
resorcinol results in increased expression of CD83 protein
CTD
PMID:21697260
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cdc20
cell division cycle 20
decreases expression
ISO
resorcinol results in decreased expression of CDC20 mRNA
CTD
PMID:22623647
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc40
cell division cycle 40
decreases expression
ISO
resorcinol results in decreased expression of CDC40 mRNA
CTD
PMID:22623647
NCBI chr20:44,273,080...44,325,605
Ensembl chr20:44,273,089...44,325,358
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
ISO
resorcinol results in increased expression of CITED2 mRNA
CTD
PMID:22623647
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Cldn1
claudin 1
decreases expression
ISO
resorcinol results in decreased expression of CLDN1 mRNA
CTD
PMID:22623647
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Colec11
collectin sub-family member 11
decreases expression
ISO
resorcinol results in decreased expression of COLEC11 mRNA
CTD
PMID:22623647
NCBI chr 6:45,223,974...45,256,640
Ensembl chr 6:45,223,980...45,271,145
G
Cxcl2
C-X-C motif chemokine ligand 2
decreases expression
ISO
resorcinol results in decreased expression of CXCL2 mRNA
CTD
PMID:22623647
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcr1
C-X-C motif chemokine receptor 1
increases expression
ISO
resorcinol results in increased expression of CXCR1 mRNA
CTD
PMID:30806763
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
G
Cxhxorf38
similar to human chromosome X open reading frame 38
decreases expression
ISO
resorcinol results in decreased expression of CXORF38 mRNA
CTD
PMID:22623647
NCBI chr X:10,128,070...10,150,904
Ensembl chr X:10,129,657...10,150,900
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
resorcinol results in increased expression of CYP1A1 mRNA
CTD
PMID:30806763
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dct
dopachrome tautomerase
decreases expression
ISO
resorcinol results in decreased expression of DCT mRNA; resorcinol results in decreased expression of DCT protein
CTD
PMID:29621941
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
G
Ddit3
DNA-damage inducible transcript 3
decreases expression
ISO
resorcinol results in decreased expression of DDIT3 mRNA
CTD
PMID:22623647
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Degs1
delta(4)-desaturase, sphingolipid 1
increases expression
ISO
resorcinol results in increased expression of DEGS1 mRNA
CTD
PMID:22623647
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
resorcinol results in decreased expression of DNAJB1 mRNA
CTD
PMID:22623647
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
resorcinol results in increased expression of DNAJB4 mRNA
CTD
PMID:27965148
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajc27
DnaJ heat shock protein family (Hsp40) member C27
decreases expression
ISO
resorcinol results in decreased expression of DNAJC27 mRNA
CTD
PMID:22623647
NCBI chr 6:27,068,713...27,098,449
Ensembl chr 6:27,068,686...27,098,449
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
resorcinol results in increased expression of DUSP1 mRNA
CTD
PMID:30806763
NCBI chr10:16,680,478...16,683,275
G
Dusp15
dual specificity phosphatase 15
decreases expression
ISO
resorcinol results in decreased expression of DUSP15 mRNA
CTD
PMID:22623647
NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
resorcinol results in increased expression of DUSP5 mRNA
CTD
PMID:22623647
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dynll2
dynein light chain LC8-type 2
decreases expression
ISO
resorcinol results in decreased expression of DYNLL2 mRNA
CTD
PMID:22623647
NCBI chr10:72,767,035...72,785,824
Ensembl chr10:72,767,035...72,785,805
G
Efcab8
EF-hand calcium binding domain 8
increases expression
ISO
resorcinol results in increased expression of EFCAB8 mRNA
CTD
PMID:22623647
NCBI chr 3:142,257,195...142,323,743
Ensembl chr 3:142,257,229...142,323,743
G
Eid2
EP300 interacting inhibitor of differentiation 2
increases expression
ISO
resorcinol results in increased expression of EID2 mRNA
CTD
PMID:22623647
NCBI chr 1:83,538,274...83,539,599
G
Eno2
enolase 2
increases expression
ISO
resorcinol results in increased expression of ENO2 mRNA
CTD
PMID:22623647
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Ero1b
endoplasmic reticulum oxidoreductase 1 beta
decreases expression
ISO
resorcinol results in decreased expression of ERO1B mRNA
CTD
PMID:22623647
NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398
G
Esr1
estrogen receptor 1
affects binding
ISO
resorcinol binds to ESR1 protein
CTD
PMID:12598185
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fam13a
family with sequence similarity 13, member A
increases expression
ISO
resorcinol results in increased expression of FAM13A mRNA
CTD
PMID:22623647
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
G
Fam241a
family with sequence similarity 241 member A
increases expression
ISO
resorcinol results in increased expression of FAM241A mRNA
CTD
PMID:22623647
NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242
G
Fancl
FA complementation group L
increases expression
ISO
resorcinol results in increased expression of FANCL mRNA
CTD
PMID:22623647
NCBI chr14:100,249,733...100,317,958
Ensembl chr14:100,248,875...100,314,255
G
Fastkd5
FAST kinase domains 5
increases expression
ISO
resorcinol results in increased expression of FASTKD5 mRNA
CTD
PMID:22623647
NCBI chr 3:117,830,219...117,847,707
Ensembl chr 3:117,830,083...117,847,820
G
Fbxl20
F-box and leucine-rich repeat protein 20
decreases expression
ISO
resorcinol results in decreased expression of FBXL20 mRNA
CTD
PMID:22623647
NCBI chr10:83,080,568...83,143,680
Ensembl chr10:83,086,551...83,144,162
G
Fbxo30
F-box protein 30
increases expression
ISO
resorcinol results in increased expression of FBXO30 mRNA
CTD
PMID:26198647
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
G
Fbxo36
F-box protein 36
decreases expression
ISO
resorcinol results in decreased expression of FBXO36 mRNA
CTD
PMID:22623647
NCBI chr 9:86,042,522...86,107,220
Ensembl chr 9:86,040,862...86,107,229
G
Frk
fyn-related Src family tyrosine kinase
decreases expression
ISO
resorcinol results in decreased expression of FRK mRNA
CTD
PMID:22623647
NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
G
Fzd7
frizzled class receptor 7
increases expression
ISO
resorcinol results in increased expression of FZD7 mRNA
CTD
PMID:22623647
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
decreases expression
ISO
resorcinol results in decreased expression of GADD45B mRNA
CTD
PMID:22623647
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gan
gigaxonin
decreases expression
ISO
resorcinol results in decreased expression of GAN mRNA
CTD
PMID:22623647
NCBI chr19:45,207,783...45,265,066
Ensembl chr19:45,207,184...45,254,107
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
resorcinol results in increased expression of GCLC mRNA
CTD
PMID:30806763
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gin1
gypsy retrotransposon integrase 1
decreases expression
ISO
resorcinol results in decreased expression of GIN1 mRNA
CTD
PMID:22623647
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
G
Glce
glucuronic acid epimerase
increases expression
ISO
resorcinol results in increased expression of GLCE mRNA
CTD
PMID:22623647
NCBI chr 8:62,546,104...62,612,144
Ensembl chr 8:62,546,107...62,612,040
G
Gpatch11
G patch domain containing 11
decreases expression
ISO
resorcinol results in decreased expression of GPATCH11 mRNA
CTD
PMID:22623647
NCBI chr 6:16,229,933...16,243,305
Ensembl chr 6:16,233,059...16,243,238
G
Gpatch2
G patch domain containing 2
decreases expression
ISO
resorcinol results in decreased expression of GPATCH2 mRNA
CTD
PMID:22623647
NCBI chr13:98,784,993...98,925,696
Ensembl chr13:98,784,969...98,925,661
G
Gpcpd1
glycerophosphocholine phosphodiesterase 1
decreases expression
ISO
resorcinol results in decreased expression of GPCPD1 mRNA
CTD
PMID:22623647
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:119,787,682...119,832,517
G
Gpnmb
glycoprotein nmb
increases expression decreases expression
ISO
resorcinol results in increased expression of GPNMB mRNA resorcinol results in decreased expression of GPNMB protein
CTD
PMID:22623647 PMID:29621941
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
H2ax
H2A.X variant histone
increases expression
ISO
resorcinol results in increased expression of H2AX mRNA
CTD
PMID:22623647
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hilpda
hypoxia inducible lipid droplet-associated
increases expression
ISO
resorcinol results in increased expression of HILPDA mRNA
CTD
PMID:22623647
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hint3
histidine triad nucleotide binding protein 3
decreases expression
ISO
resorcinol results in decreased expression of HINT3 mRNA
CTD
PMID:22623647
NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721
G
Hmox1
heme oxygenase 1
increases expression
ISO
resorcinol results in increased expression of HMOX1 mRNA
CTD
PMID:30806763
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnph2
heterogeneous nuclear ribonucleoprotein H2
increases expression
ISO
resorcinol results in increased expression of HNRNPH2 mRNA
CTD
PMID:22623647
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
G
Hnrnph3
heterogeneous nuclear ribonucleoprotein H3
increases expression
ISO
resorcinol results in increased expression of HNRNPH3 mRNA
CTD
PMID:22623647
NCBI chr20:25,616,400...25,625,814
Ensembl chr20:25,614,733...25,625,750
G
Hoxd1
homeo box D1
increases expression
ISO
resorcinol results in increased expression of HOXD1 mRNA
CTD
PMID:22623647
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hs3st3b1
heparan sulfate-glucosamine 3-sulfotransferase 3B1
decreases expression
ISO
resorcinol results in decreased expression of HS3ST3B1 mRNA
CTD
PMID:22623647
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
decreases expression
ISO
resorcinol results in decreased expression of HSPA1A mRNA
CTD
PMID:22623647
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
decreases expression
ISO
resorcinol results in decreased expression of HSPA1B mRNA
CTD
PMID:22623647
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa4l
heat shock protein family A (Hsp70) member 4 like
decreases expression
ISO
resorcinol results in decreased expression of HSPA4L mRNA
CTD
PMID:22623647
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
resorcinol results in increased expression of ICAM1 mRNA; resorcinol results in increased expression of ICAM1 protein
CTD
PMID:30806763
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
decreases expression
ISO
resorcinol analog results in decreased expression of ID1 protein
CTD
PMID:24910342
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
resorcinol analog results in increased expression of ID2 protein
CTD
PMID:24910342
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
decreases expression
ISO
resorcinol results in decreased expression of ID3 mRNA
CTD
PMID:22623647
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
resorcinol results in increased expression of IDI1 mRNA
CTD
PMID:22623647
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ikzf5
IKAROS family zinc finger 5
decreases expression
ISO
resorcinol results in decreased expression of IKZF5 mRNA
CTD
PMID:22623647
NCBI chr 1:186,169,108...186,188,847
Ensembl chr 1:186,170,788...186,188,834
G
Il18
interleukin 18
increases expression
ISO
resorcinol results in increased expression of IL18 mRNA; resorcinol results in increased expression of IL18 protein
CTD
PMID:23063874 PMID:30806763
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases expression
ISO
resorcinol results in increased expression of IL1A mRNA
CTD
PMID:30806763
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
ISO
resorcinol results in increased expression of IL1B mRNA
CTD
PMID:21697260
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
increases expression
ISO
resorcinol results in increased expression of IL1R2 mRNA
CTD
PMID:30806763
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Ing3
inhibitor of growth family, member 3
decreases expression
ISO
resorcinol results in decreased expression of ING3 mRNA
CTD
PMID:22623647
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
G
Insig2
insulin induced gene 2
increases expression
ISO
resorcinol results in increased expression of INSIG2 mRNA
CTD
PMID:22623647
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
decreases expression
ISO
resorcinol results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:22623647
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
resorcinol results in decreased expression of JDP2 mRNA
CTD
PMID:22623647
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jmy
junction mediating and regulatory protein, p53 cofactor
decreases expression
ISO
resorcinol results in decreased expression of JMY mRNA
CTD
PMID:22623647
NCBI chr 2:24,662,104...24,730,955
Ensembl chr 2:24,668,854...24,731,006
G
Khdc4
KH domain containing 4, pre-mRNA splicing factor
increases expression
ISO
resorcinol results in increased expression of KHDC4 mRNA
CTD
PMID:22623647
NCBI chr 2:174,149,059...174,177,816
Ensembl chr 2:174,149,141...174,177,504
G
Klhl11
kelch-like family member 11
decreases expression
ISO
resorcinol results in decreased expression of KLHL11 mRNA
CTD
PMID:22623647
NCBI chr10:85,398,487...85,409,049
Ensembl chr10:85,398,487...85,409,049
G
Leng8
leukocyte receptor cluster member 8
increases expression
ISO
resorcinol results in increased expression of LENG8 mRNA
CTD
PMID:22623647
NCBI chr 1:70,040,785...70,052,662
Ensembl chr 1:70,040,785...70,052,488
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
resorcinol results in increased expression of LIF mRNA
CTD
PMID:26198647
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lin54
lin-54 DREAM MuvB core complex component
increases expression
ISO
resorcinol results in increased expression of LIN54 mRNA
CTD
PMID:22623647
NCBI chr14:9,129,775...9,188,244
Ensembl chr14:9,130,336...9,187,790
G
Lipg
lipase G, endothelial type
increases expression
ISO
resorcinol results in increased expression of LIPG mRNA
CTD
PMID:22623647
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Llph
LLP homolog, long-term synaptic facilitation factor
increases expression
ISO
resorcinol results in increased expression of LLPH mRNA
CTD
PMID:22623647
NCBI chr 7:55,735,317...55,740,341
Ensembl chr 7:55,735,400...55,740,339
G
LOC100909998
zinc finger protein 2-like
decreases expression
ISO
resorcinol results in decreased expression of ZNF2 mRNA
CTD
PMID:22623647
NCBI chr 3:114,793,783...114,818,395
Ensembl chr 3:114,809,723...114,818,387 Ensembl chr 3:114,809,723...114,818,387
G
Lpar6
lysophosphatidic acid receptor 6
increases expression
ISO
resorcinol results in increased expression of LPAR6 mRNA
CTD
PMID:22623647
NCBI chr15:48,416,548...48,418,357
Ensembl chr15:48,416,544...48,422,331
G
Lpxn
leupaxin
decreases expression
ISO
resorcinol results in decreased expression of LPXN mRNA
CTD
PMID:22623647
NCBI chr 1:209,928,297...209,963,085
Ensembl chr 1:209,929,202...209,963,084
G
Lrig3
leucine-rich repeats and immunoglobulin-like domains 3
decreases expression
ISO
resorcinol results in decreased expression of LRIG3 mRNA
CTD
PMID:22623647
NCBI chr 7:61,816,313...61,866,275
Ensembl chr 7:61,816,342...61,866,481
G
Lrrc8d
leucine rich repeat containing 8 VRAC subunit D
decreases expression
ISO
resorcinol results in decreased expression of LRRC8D mRNA
CTD
PMID:22623647
NCBI chr14:4,029,971...4,134,922
Ensembl chr14:4,029,473...4,135,877
G
Luc7l3
LUC7-like 3 pre-mRNA splicing factor
increases expression
ISO
resorcinol results in increased expression of LUC7L3 mRNA
CTD
PMID:22623647
NCBI chr10:79,240,050...79,276,555
Ensembl chr10:79,240,563...79,276,538
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
increases lipidation
ISO
resorcinol analog results in increased lipidation of MAP1LC3A protein
CTD
PMID:24910342
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map3k13
mitogen-activated protein kinase kinase kinase 13
decreases expression
ISO
resorcinol results in decreased expression of MAP3K13 mRNA
CTD
PMID:22623647
NCBI chr11:79,094,087...79,235,181
Ensembl chr11:79,097,247...79,235,181
G
Mfsd9
major facilitator superfamily domain containing 9
decreases expression
ISO
resorcinol results in decreased expression of MFSD9 mRNA
CTD
PMID:22623647
NCBI chr 9:43,019,611...43,039,100
Ensembl chr 9:43,019,618...43,039,176
G
Mitf
melanocyte inducing transcription factor
decreases expression
ISO
resorcinol results in decreased expression of MITF mRNA; resorcinol results in decreased expression of MITF protein
CTD
PMID:25584612 PMID:29621941
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
resorcinol results in increased expression of MMP10 mRNA
CTD
PMID:30806763
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp3
matrix metallopeptidase 3
increases expression
ISO
resorcinol results in increased expression of MMP3 mRNA
CTD
PMID:30806763
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Moap1
modulator of apoptosis 1
increases expression
ISO
resorcinol results in increased expression of MOAP1 mRNA
CTD
PMID:22623647
NCBI chr 6:121,882,565...121,884,500
Ensembl chr 6:121,882,366...121,898,643
G
Mpo
myeloperoxidase
multiple interactions
ISO
resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein] resorcinol inhibits the reaction [[[MPO protein co-treated with Chlorides co-treated with Threonine co-treated with Hydrogen Peroxide] results in increased chemical synthesis of Acrolein] which results in increased phosphorylation of AKT1 protein]
CTD
PMID:26262998
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mrpl50
mitochondrial ribosomal protein L50
increases expression
ISO
resorcinol results in increased expression of MRPL50 mRNA
CTD
PMID:22623647
NCBI chr 5:63,867,437...63,872,591
G
N6amt1
N-6 adenine-specific DNA methyltransferase 1
decreases expression
ISO
resorcinol results in decreased expression of N6AMT1 mRNA
CTD
PMID:22623647
NCBI chr11:26,584,750...26,597,790
Ensembl chr11:26,584,724...26,608,248
G
Nanos1
nanos C2HC-type zinc finger 1
increases expression
ISO
resorcinol results in increased expression of NANOS1 mRNA
CTD
PMID:22623647
NCBI chr 1:259,897,663...259,901,561
Ensembl chr 1:259,897,939...259,898,730
G
Ncbp2as2
NCBP2 antisense 2 (head to head)
increases expression
ISO
resorcinol results in increased expression of NCBP2AS2 mRNA
CTD
PMID:22623647
NCBI chr11:68,829,950...68,830,715
Ensembl chr11:68,829,983...68,830,708
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
resorcinol results in increased expression of NDRG1 mRNA
CTD
PMID:22623647
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nexn
nexilin (F actin binding protein)
decreases expression
ISO
resorcinol results in decreased expression of NEXN mRNA
CTD
PMID:22623647
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
G
Nfatc2ip
nuclear factor of activated T-cells 2 interacting protein
increases expression
ISO
resorcinol results in increased expression of NFATC2IP mRNA
CTD
PMID:22623647
NCBI chr 1:180,954,834...180,971,847
Ensembl chr 1:180,955,043...180,971,747
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
ISO
resorcinol results in decreased expression of NFE2L2 mRNA
CTD
PMID:31967339
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
resorcinol results in increased expression of NQO1 mRNA
CTD
PMID:30806763
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
resorcinol results in increased expression of NR0B2 mRNA
CTD
PMID:22623647
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr6a1
nuclear receptor subfamily 6, group A, member 1
decreases expression
ISO
resorcinol results in decreased expression of NR6A1 mRNA
CTD
PMID:22623647
NCBI chr 3:22,495,109...22,683,132
Ensembl chr 3:22,496,943...22,683,131
G
Nsun3
NOP2/Sun RNA methyltransferase 3
decreases expression
ISO
resorcinol results in decreased expression of NSUN3 mRNA
CTD
PMID:22623647
NCBI chr11:37,490,832...37,575,607
Ensembl chr11:37,490,838...37,568,543
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
ISO
resorcinol results in decreased expression of NUPR1 mRNA
CTD
PMID:22623647
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
increases expression
ISO
resorcinol results in increased expression of PFKFB3 mRNA
CTD
PMID:22623647
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pgrmc2
progesterone receptor membrane component 2
increases expression
ISO
resorcinol results in increased expression of PGRMC2 mRNA
CTD
PMID:22623647
NCBI chr 2:124,068,257...124,084,155
Ensembl chr 2:124,068,260...124,084,155
G
Plpp6
phospholipid phosphatase 6
increases expression
ISO
resorcinol results in increased expression of PLPP6 mRNA
CTD
PMID:22623647
NCBI chr 1:226,679,100...226,681,952
Ensembl chr 1:226,679,100...226,681,949
G
Pnisr
PNN interacting serine and arginine rich protein
increases expression
ISO
resorcinol results in increased expression of PNISR mRNA
CTD
PMID:22623647
NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:35,395,965...35,422,844
G
Pnma1
PNMA family member 1
increases expression
ISO
resorcinol results in increased expression of PNMA1 mRNA
CTD
PMID:22623647
NCBI chr 6:103,782,244...103,784,029
Ensembl chr 6:103,773,889...103,784,567
G
Pnn
pinin, desmosome associated protein
increases expression
ISO
resorcinol results in increased expression of PNN mRNA
CTD
PMID:22623647
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
G
Prrg1
proline rich and Gla domain 1
increases expression
ISO
resorcinol results in increased expression of PRRG1 mRNA
CTD
PMID:22623647
NCBI chr X:42,494,256...42,606,612
Ensembl chr X:42,494,256...42,606,588
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form]
CTD
PMID:26262998
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
resorcinol results in increased expression of PTGR1 mRNA
CTD
PMID:22623647
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptgr3
prostaglandin reductase 3
increases expression
ISO
resorcinol results in increased expression of PTGR3 mRNA
CTD
PMID:22623647
NCBI chr18:77,454,435...77,463,785
Ensembl chr18:77,454,435...77,463,785
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression decreases expression
ISO
resorcinol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] resorcinol results in increased expression of PTGS2 mRNA resorcinol results in decreased expression of PTGS2 mRNA
CTD
PMID:10783318 PMID:30806763
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rab42
RAB42, member RAS oncogene family
increases expression
ISO
resorcinol results in increased expression of RAB42 mRNA
CTD
PMID:22623647
NCBI chr 5:144,497,159...144,498,829
Ensembl chr 5:144,496,215...144,498,848
G
Rbm12
RNA binding motif protein 12
increases expression
ISO
resorcinol results in increased expression of RBM12 mRNA
CTD
PMID:22623647
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915 Ensembl chr 3:144,611,623...144,629,915
G
Rgcc
regulator of cell cycle
increases expression
ISO
resorcinol results in increased expression of RGCC mRNA
CTD
PMID:22623647
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rlim
ring finger protein, LIM domain interacting
decreases expression
ISO
resorcinol results in decreased expression of RLIM mRNA
CTD
PMID:22623647
NCBI chr X:68,983,259...69,004,368
Ensembl chr X:68,988,375...69,004,271
G
Rnd1
Rho family GTPase 1
decreases expression
ISO
resorcinol results in decreased expression of RND1 mRNA
CTD
PMID:22623647
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rraga
Ras-related GTP binding A
increases expression
ISO
resorcinol results in increased expression of RRAGA mRNA
CTD
PMID:22623647
NCBI chr 5:101,113,341...101,114,936
Ensembl chr 5:101,112,859...101,114,510
G
Rsrp1
arginine and serine rich protein 1
increases expression
ISO
resorcinol results in increased expression of RSRP1 mRNA
CTD
PMID:22623647
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
Samd4a
sterile alpha motif domain containing 4A
decreases expression
ISO
resorcinol results in decreased expression of SAMD4A mRNA
CTD
PMID:22623647
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
G
Sdsl
serine dehydratase-like
decreases expression
ISO
resorcinol results in decreased expression of SDSL mRNA
CTD
PMID:22623647
NCBI chr12:36,099,693...36,109,914
Ensembl chr12:36,099,693...36,109,906
G
Sepsecs
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
decreases expression
ISO
resorcinol results in decreased expression of SEPSECS mRNA
CTD
PMID:22623647
NCBI chr14:58,311,484...58,341,745
Ensembl chr14:58,311,499...58,341,740
G
Serpinb3
serpin family B member 3
increases expression
ISO
resorcinol results in increased expression of SERPINB3 mRNA
CTD
PMID:30806763
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
G
Serpinb9
serpin family B member 9
increases expression
ISO
resorcinol results in increased expression of SERPINB9 mRNA
CTD
PMID:22623647
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Sesn3
sestrin 3
decreases expression
ISO
resorcinol results in decreased expression of SESN3 mRNA
CTD
PMID:22623647
NCBI chr 8:11,133,822...11,189,436
Ensembl chr 8:11,133,678...11,185,842
G
Skil
SKI-like proto-oncogene
decreases expression
ISO
resorcinol results in decreased expression of SKIL mRNA
CTD
PMID:22623647
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Slc17a2
solute carrier family 17, member 2
decreases expression
ISO
resorcinol results in decreased expression of SLC17A2 mRNA
CTD
PMID:22623647
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
resorcinol results in increased expression of SLC2A3 mRNA
CTD
PMID:22623647
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc44a2
solute carrier family 44 member 2
decreases expression
ISO
resorcinol results in decreased expression of SLC44A2 mRNA
CTD
PMID:22623647
NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342
G
Slc51b
SLC51 subunit beta
decreases expression
ISO
resorcinol results in decreased expression of SLC51B mRNA
CTD
PMID:22623647
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slc6a8
solute carrier family 6 member 8
increases expression
ISO
resorcinol results in increased expression of SLC6A8 mRNA
CTD
PMID:22623647
NCBI chr X:151,384,675...151,393,979
Ensembl chr X:151,384,675...151,393,979
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
resorcinol results in decreased expression of SLC7A11 mRNA
CTD
PMID:22623647 PMID:26198647
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Smad7
SMAD family member 7
decreases expression
ISO
resorcinol results in decreased expression of SMAD7 mRNA
CTD
PMID:22623647
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
G
Smim19
small integral membrane protein 19
decreases expression
ISO
resorcinol results in decreased expression of SMIM19 mRNA
CTD
PMID:22623647
NCBI chr16:69,551,507...69,564,323
Ensembl chr16:69,553,916...69,567,245
G
Snora61
small nucleolar RNA, H/ACA box 61
increases expression
ISO
resorcinol results in increased expression of SNORA61 mRNA
CTD
PMID:22623647
NCBI chr 5:144,506,420...144,506,549
Ensembl chr 5:144,506,420...144,506,549
G
Socs7
suppressor of cytokine signaling 7
decreases expression
ISO
resorcinol results in decreased expression of SOCS7 mRNA
CTD
PMID:22623647
NCBI chr10:82,352,159...82,388,829
Ensembl chr10:82,351,680...82,388,830
G
Spin4
spindlin family, member 4
increases expression
ISO
resorcinol results in increased expression of SPIN4 mRNA
CTD
PMID:22623647
NCBI chr X:59,888,728...59,892,817
Ensembl chr X:59,891,581...59,892,330
G
Sptssa
serine palmitoyltransferase, small subunit A
increases expression
ISO
resorcinol results in increased expression of SPTSSA mRNA
CTD
PMID:22623647
NCBI chr 6:72,144,714...72,156,130
Ensembl chr 6:72,144,714...72,156,214
G
Srsf5
serine and arginine rich splicing factor 5
increases expression
ISO
resorcinol results in increased expression of SRSF5 mRNA
CTD
PMID:22623647
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
Srxn1
sulfiredoxin 1
increases expression
ISO
resorcinol results in increased expression of SRXN1 mRNA
CTD
PMID:22003191
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Stbd1
starch binding domain 1
increases expression
ISO
resorcinol results in increased expression of STBD1 mRNA
CTD
PMID:22623647
NCBI chr14:15,470,452...15,473,857
Ensembl chr14:15,469,582...15,477,443
G
Stk17b
serine/threonine kinase 17b
decreases expression
ISO
resorcinol results in decreased expression of STK17B mRNA
CTD
PMID:22623647
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
G
Taf7
TATA-box binding protein associated factor 7
increases expression
ISO
resorcinol results in increased expression of TAF7 mRNA
CTD
PMID:22623647
NCBI chr18:29,459,937...29,462,086
Ensembl chr18:29,452,943...29,462,134
G
Tafa5
TAFA chemokine like family member 5
increases expression
ISO
resorcinol results in increased expression of TAFA5 mRNA
CTD
PMID:22623647
NCBI chr 7:118,613,731...118,835,016
Ensembl chr 7:118,613,889...118,834,353
G
Tagln
transgelin
decreases expression
ISO
resorcinol results in decreased expression of TAGLN mRNA
CTD
PMID:22623647
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tatdn3
TatD DNase domain containing 3
decreases expression
ISO
resorcinol results in decreased expression of TATDN3 mRNA
CTD
PMID:22623647
NCBI chr13:102,634,254...102,649,069
Ensembl chr13:102,634,258...102,649,063
G
Tet1
tet methylcytosine dioxygenase 1
increases expression
ISO
resorcinol results in increased expression of TET1 mRNA
CTD
PMID:22623647
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
G
Tgfa
transforming growth factor alpha
multiple interactions
ISO
resorcinol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA]
CTD
PMID:10783318
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Timm10b
translocase of inner mitochondrial membrane 10B
increases expression
ISO
resorcinol results in increased expression of TIMM10B mRNA
CTD
PMID:22623647
NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642
G
Tmcc1
transmembrane and coiled-coil domain family 1
increases expression
ISO
resorcinol results in increased expression of TMCC1 mRNA
CTD
PMID:22623647
NCBI chr 4:149,069,252...149,239,585
Ensembl chr 4:149,069,260...149,239,620
G
Tmem169
transmembrane protein 169
decreases expression
ISO
resorcinol results in decreased expression of TMEM169 mRNA
CTD
PMID:22623647
NCBI chr 9:73,926,553...73,950,679
Ensembl chr 9:73,926,568...73,950,576
G
Tmem170a
transmembrane protein 170A
decreases expression
ISO
resorcinol results in decreased expression of TMEM170A mRNA
CTD
PMID:22623647
NCBI chr19:39,833,947...39,846,807
Ensembl chr19:39,833,980...39,846,783
G
Tnf
tumor necrosis factor
increases expression
ISO
resorcinol results in increased expression of TNF mRNA
CTD
PMID:30806763
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53inp2
tumor protein p53 inducible nuclear protein 2
increases expression
ISO
resorcinol results in increased expression of TP53INP2 mRNA
CTD
PMID:22623647
NCBI chr 3:143,881,427...143,890,104
Ensembl chr 3:143,882,021...143,890,097
G
Tpo
thyroid peroxidase
multiple interactions decreases activity
ISO EXP
resorcinol binds to and results in decreased activity of TPO protein resorcinol results in decreased activity of TPO protein
CTD
PMID:26865668 PMID:31629072
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Trim50
tripartite motif-containing 50
decreases expression
ISO
resorcinol results in decreased expression of TRIM50 mRNA
CTD
PMID:22623647
NCBI chr12:21,300,784...21,317,668
Ensembl chr12:21,300,785...21,317,668
G
Tuba4a
tubulin, alpha 4A
increases expression
ISO
resorcinol results in increased expression of TUBA4A mRNA
CTD
PMID:22623647
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb1
tubulin, beta 1 class VI
increases expression
ISO
resorcinol results in increased expression of TUBB1 mRNA
CTD
PMID:22623647
NCBI chr 3:163,247,990...163,257,460
Ensembl chr 3:163,247,967...163,256,063
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
ISO
resorcinol results in increased expression of TUBB4B mRNA
CTD
PMID:22623647
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tuft1
tuftelin 1
decreases expression
ISO
resorcinol results in decreased expression of TUFT1 mRNA
CTD
PMID:22623647
NCBI chr 2:182,259,457...182,306,296
Ensembl chr 2:182,260,398...182,306,192
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
resorcinol results in increased expression of TXNRD1 mRNA
CTD
PMID:30806763
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tyr
tyrosinase
decreases activity multiple interactions decreases expression
ISO
resorcinol results in decreased activity of TYR protein [resorcinol co-treated with Cycloheximide] results in increased expression of TYR protein; resorcinol results in decreased expression of and results in decreased activity of TYR protein; SB 203580 inhibits the reaction [[resorcinol co-treated with Cycloheximide] results in increased expression of TYR protein]; SB 203580 inhibits the reaction [resorcinol results in decreased activity of TYR protein] resorcinol results in decreased expression of TYR mRNA; resorcinol results in decreased expression of TYR protein
CTD
PMID:25584612 PMID:29621941 PMID:30849679
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Tyrp1
tyrosinase-related protein 1
decreases expression
ISO
resorcinol results in decreased expression of TYRP1 mRNA; resorcinol results in decreased expression of TYRP1 protein
CTD
PMID:29621941
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
G
Ubqln2
ubiquilin 2
increases expression
ISO
resorcinol results in increased expression of UBQLN2 mRNA
CTD
PMID:22623647
NCBI chr X:17,853,086...17,856,505
Ensembl chr X:17,853,114...17,856,505
G
Wdcp
WD repeat and coiled coil containing
increases expression
ISO
resorcinol results in increased expression of WDCP mRNA
CTD
PMID:22623647
NCBI chr 6:27,850,684...27,865,540
Ensembl chr 6:27,850,698...27,865,536
G
Yju2b
YJU2 splicing factor homolog B
decreases expression
ISO
resorcinol results in decreased expression of YJU2B mRNA
CTD
PMID:22623647
NCBI chr19:23,894,587...23,906,084
Ensembl chr19:23,894,649...23,906,077
G
Zbtb20
zinc finger and BTB domain containing 20
decreases expression
ISO
resorcinol results in decreased expression of ZBTB20 mRNA
CTD
PMID:22623647
NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210
G
Zbtb37
zinc finger and BTB domain containing 37
decreases expression
ISO
resorcinol results in decreased expression of ZBTB37 mRNA
CTD
PMID:22623647
NCBI chr13:73,271,920...73,303,427
Ensembl chr13:73,280,544...73,337,124
G
Zfp347
zinc finger protein 347
decreases expression
ISO
resorcinol results in decreased expression of ZNF14 mRNA
CTD
PMID:22623647
NCBI chr 7:7,460,543...7,479,378
Ensembl chr 7:7,459,701...7,484,430
G
Zfp35
zinc finger protein 35
decreases expression
ISO
resorcinol results in decreased expression of ZNF79 mRNA
CTD
PMID:22623647
NCBI chr18:15,268,852...15,284,334
Ensembl chr18:15,268,814...15,285,088
G
Zfyve26
zinc finger FYVE-type containing 26
increases expression
ISO
resorcinol results in increased expression of ZFYVE26 mRNA
CTD
PMID:22623647
NCBI chr 6:98,031,874...98,095,538
Ensembl chr 6:98,032,520...98,095,480
G
Zic2
Zic family member 2
increases expression
ISO
resorcinol results in increased expression of ZIC2 mRNA
CTD
PMID:22623647
NCBI chr15:99,576,697...99,581,522
Ensembl chr15:99,576,697...99,581,522
G
Znf8
zinc finger protein 8
decreases expression
ISO
resorcinol results in decreased expression of ZNF8 mRNA
CTD
PMID:22623647
NCBI chr 1:73,498,526...73,511,929
Ensembl chr 1:73,498,491...73,511,119
G
Cyb5a
cytochrome b5 type A
multiple interactions
EXP ISO
CYB5A protein promotes the reaction [CYP1A1 protein results in increased oxidation of 1-phenylazo-2-naphthol] CYB5A protein inhibits the reaction [CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYB5A protein inhibits the reaction [CYP2C19 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYB5A protein inhibits the reaction [CYP2D6 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYB5A protein promotes the reaction [CYP1A1 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYB5A protein promotes the reaction [CYP2A6 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYB5A protein promotes the reaction [CYP3A4 protein results in increased oxidation of 1-phenylazo-2-naphthol]
CTD
PMID:17159775 PMID:19358889
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression increases oxidation
ISO EXP
CYB5A protein promotes the reaction [CYP1A1 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYP1A1 protein results in increased metabolism of and results in increased activity of 1-phenylazo-2-naphthol 1-phenylazo-2-naphthol results in increased expression of CYP1A1 mRNA; 1-phenylazo-2-naphthol results in increased expression of CYP1A1 protein 1-phenylazo-2-naphthol promotes the reaction [aristolochic acid I results in increased expression of and results in increased activity of CYP1A1 protein]; 1-phenylazo-2-naphthol results in increased expression of and results in increased activity of CYP1A1 protein; [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with POR protein] results in increased metabolism of 1-phenylazo-2-naphthol; CYB5A protein promotes the reaction [CYP1A1 protein results in increased oxidation of 1-phenylazo-2-naphthol]; CYP1A1 protein results in increased metabolism of and results in increased activity of 1-phenylazo-2-naphthol
CTD
PMID:12384524 PMID:15766589 PMID:17159775 PMID:18418879 PMID:23289503 PMID:24530354 PMID:26845733 More...
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression increases oxidation
ISO EXP
CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol] 1-phenylazo-2-naphthol results in increased expression of CYP1A2 mRNA 1-phenylazo-2-naphthol affects the expression of and affects the activity of CYP1A2 protein; [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of CYP1A2 mRNA; [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in increased expression of and results in increased activity of CYP1A2 protein
CTD
PMID:17159775 PMID:26845733
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases oxidation
ISO
CYP1B1 protein results in increased oxidation of 1-phenylazo-2-naphthol
CTD
PMID:17159775
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases oxidation multiple interactions
ISO
CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol CYB5A protein inhibits the reaction [CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol]
CTD
PMID:17159775
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases activity multiple interactions
EXP
1-phenylazo-2-naphthol results in decreased activity of CYP2C11 protein [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in decreased activity of CYP2C11 protein
CTD
PMID:26845733
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions increases oxidation
ISO
CYB5A protein inhibits the reaction [CYP2C19 protein results in increased oxidation of 1-phenylazo-2-naphthol]
CTD
PMID:17159775
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases oxidation
ISO
CYP2C8 protein results in increased oxidation of 1-phenylazo-2-naphthol
CTD
PMID:17159775
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions increases oxidation
ISO
CYB5A protein inhibits the reaction [CYP2D6 protein results in increased oxidation of 1-phenylazo-2-naphthol]
CTD
PMID:17159775
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases oxidation
ISO
CYP2E1 protein results in increased oxidation of 1-phenylazo-2-naphthol
CTD
PMID:17159775
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases oxidation multiple interactions
ISO
CYP3A4 protein results in increased oxidation of 1-phenylazo-2-naphthol CYB5A protein promotes the reaction [CYP3A4 protein results in increased oxidation of 1-phenylazo-2-naphthol]
CTD
PMID:17159775 PMID:19358889
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
F3
coagulation factor III, tissue factor
increases expression
ISO
1-phenylazo-2-naphthol results in increased expression of F3 protein
CTD
PMID:25569083
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
1-phenylazo-2-naphthol results in increased expression of GSTP1 mRNA
CTD
PMID:2563599
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases expression
EXP
1-phenylazo-2-naphthol results in increased expression of and results in increased activity of NQO1 protein; [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of NQO1 mRNA; [aristolochic acid I co-treated with 1-phenylazo-2-naphthol] results in increased expression of and results in increased activity of NQO1 protein 1-phenylazo-2-naphthol results in increased expression of NQO1 mRNA
CTD
PMID:23289503 PMID:26845733
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Por
cytochrome p450 oxidoreductase
multiple interactions
EXP
[CYP1A1 protein co-treated with POR protein] results in increased metabolism of 1-phenylazo-2-naphthol
CTD
PMID:24530354
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Ahr
aryl hydrocarbon receptor
affects localization multiple interactions
ISO EXP
sudan III affects the localization of AHR protein [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased activity of CYP2C11 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased expression of CYP2C11 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased expression of CYP2C11 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A23-3A1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B1 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B2 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A2 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A23-3A1 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A23-3A1 protein]; [sudan III binds to AHR protein] which results in decreased activity of CYP2C11 protein; sudan III binds to and results in increased activity of AHR protein [sudan III affects the localization of AHR protein] promotes the reaction [AHR protein binds to ARNT protein]; [sudan III affects the localization of AHR protein] which results in increased expression of CYP1A1 mRNA; sudan III binds to and results in increased activity of AHR protein
CTD
PMID:15585952 PMID:15788368 PMID:22287322
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
ISO
[sudan III affects the localization of AHR protein] promotes the reaction [AHR protein binds to ARNT protein]
CTD
PMID:22287322
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression increases activity multiple interactions
ISO EXP
sudan III results in increased expression of CYP1A1 mRNA sudan III results in increased expression of CYP1A1 mRNA; sudan III results in increased expression of CYP1A1 protein sudan III results in increased activity of CYP1A1 protein [sudan III affects the localization of AHR protein] which results in increased expression of CYP1A1 mRNA; NR1I3 protein promotes the reaction [sudan III results in increased expression of CYP1A1 mRNA]
CTD
PMID:18418879 PMID:20308224 PMID:22287322
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
sudan III results in increased expression of CYP1A2 protein
CTD
PMID:20308224
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
multiple interactions decreases expression
EXP
[sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B1 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B1 protein]; sudan III results in decreased expression of and results in decreased activity of CYP2B1 protein sudan III results in decreased expression of CYP2B1 mRNA
CTD
PMID:15788368
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions decreases expression
EXP
[sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B2 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B2 protein]; sudan III results in decreased expression of and results in decreased activity of CYP2B2 protein sudan III results in decreased expression of CYP2B2 mRNA
CTD
PMID:15788368
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions decreases expression
EXP
[sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased activity of CYP2C11 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased expression of CYP2C11 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased expression of CYP2C11 protein]; [sudan III binds to AHR protein] which results in decreased activity of CYP2C11 protein; sudan III results in decreased expression of and results in decreased activity of CYP2C11 protein sudan III results in decreased expression of CYP2C11 mRNA
CTD
PMID:15788368
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions decreases expression
EXP
[sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A2 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A2 protein]; sudan III results in decreased expression of and results in decreased activity of CYP3A2 protein sudan III results in decreased expression of CYP3A2 mRNA
CTD
PMID:15788368
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
multiple interactions decreases expression
EXP
[sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A23-3A1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A23-3A1 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A23-3A1 protein]; sudan III results in decreased expression of and results in decreased activity of CYP3A23-3A1 protein sudan III results in decreased expression of CYP3A23-3A1 mRNA
CTD
PMID:15788368
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
EXP
sudan III results in decreased expression of CYP4A1 mRNA
CTD
PMID:15585952
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4a2
cytochrome P450, family 4, subfamily a, polypeptide 2
decreases expression
EXP
sudan III results in decreased expression of CYP4A2 mRNA
CTD
PMID:15585952
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
decreases expression
EXP
sudan III results in decreased expression of CYP4A3 mRNA
CTD
PMID:15585952
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
sudan III results in increased expression of NQO1 mRNA
CTD
PMID:20308224
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
NR1I3 protein promotes the reaction [sudan III results in increased expression of CYP1A1 mRNA]
CTD
PMID:22287322
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression multiple interactions
ISO EXP
sudan III results in decreased expression of PPARA protein sudan III results in decreased expression of PPARA mRNA [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased activity of CYP2C11 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased expression of CYP2C11 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in decreased expression of CYP2C11 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP3A23-3A1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B1 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B1 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B2 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP2B2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A2 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A2 protein]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A23-3A1 mRNA]; [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased expression of CYP3A23-3A1 protein]
CTD
PMID:15585952 PMID:15788368
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Rxra
retinoid X receptor alpha
decreases expression
ISO
sudan III results in decreased expression of RXRA protein
CTD
PMID:15585952
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
Scarlet Red results in increased expression of CYP1A1 mRNA; Scarlet Red results in increased expression of CYP1A1 protein
CTD
PMID:18418879
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Gli1
GLI family zinc finger 1
multiple interactions
ISO
Tolnaftate inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA]
CTD
PMID:20434536
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Tolnaftate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Il4
interleukin 4
multiple interactions decreases secretion decreases expression
ISO
1-Methyl-3-isobutylxanthine inhibits the reaction [Tolnaftate results in decreased expression of IL4 mRNA]; 1-Methyl-3-isobutylxanthine inhibits the reaction [Tolnaftate results in decreased secretion of IL4 protein]; Bucladesine inhibits the reaction [Tolnaftate results in decreased expression of IL4 mRNA]; Bucladesine inhibits the reaction [Tolnaftate results in decreased secretion of IL4 protein]; Colforsin inhibits the reaction [Tolnaftate results in decreased expression of IL4 mRNA]; Colforsin inhibits the reaction [Tolnaftate results in decreased secretion of IL4 protein]
CTD
PMID:11886533 PMID:15284827
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
multiple interactions decreases expression decreases secretion
ISO
1-Methyl-3-isobutylxanthine inhibits the reaction [Tolnaftate results in decreased expression of IL5 mRNA]; 1-Methyl-3-isobutylxanthine inhibits the reaction [Tolnaftate results in decreased secretion of IL5 protein]; Bucladesine inhibits the reaction [Tolnaftate results in decreased expression of IL5 mRNA]; Bucladesine inhibits the reaction [Tolnaftate results in decreased secretion of IL5 protein]; Colforsin inhibits the reaction [Tolnaftate results in decreased expression of IL5 mRNA]; Colforsin inhibits the reaction [Tolnaftate results in decreased secretion of IL5 protein]
CTD
PMID:11886533 PMID:15284827
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Shh
sonic hedgehog signaling molecule
multiple interactions
ISO
Tolnaftate inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA]
CTD
PMID:20434536
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all